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Parth D. Shah: The role of pharmacy in HPV vaccination of U.S. adolescents 
(Under the direction of Noel Brewer) 
Purpose. Pharmacies could play a meaningful role in improving HPV vaccine uptake in 
US adolescents. This dissertation aimed to evaluate the intrapersonal, provider, and structural 
factors related to pharmacies as vaccination settings that might motivate parents to obtain 
pharmacist-provided HPV vaccinations for their children. 
Methods. Aim One: I conducted structural equation modeling to evaluate how the type of 
pharmacy parents (n=1,504) use to get medications for their adolescent children was associated 
with willingness to get these children HPV vaccine from pharmacists. Aim Two: I conducted 
analysis of variance and multiple regression models to examine how parents (n=1,500) perceived 
relative advantages of vaccine delivery in pharmacies compared to doctors’ offices. Aim 
Three: I conducted geospatial analyses to assess whether community pharmacists can improve 
access to HPV vaccination services in primary health care shortage areas in Texas, which allows 
pharmacists to immunize adolescents. 
Results. Aim One: Compared to parents who used chain pharmacies, parents who used 
independent pharmacies were less willing to get their adolescent children HPV vaccine from 
pharmacists (β=-.094; p=.001). Service quality and satisfaction suppressed this relationship. Aim 
Two: Parents were more willing to get their children HPV vaccine from a pharmacist if they 
indicated more relative advantages in vaccine delivery in pharmacies (β=.29; p<.001), and if they 
believed vaccine delivery features related to patient accessibility were more important than 
    
	
iv 
features related to the health care environment (β=.20; p<.001). Aim Three: When pharmacists 
were included as adolescent vaccine providers along with primary care physicians, census tracts 
shifted towards adequate coverage in 35% (1,055/3013) of urban tracts and in 18% (92/521) of 
rural tracts. 
Conclusion. Pharmacies could increase HPV vaccine uptake by improving parents’ perception 
of service quality at pharmacies they use. Pharmacies that provide adolescent vaccinations 
should capitalize on their relative advantages in patient accessibility over doctors’ offices, while 
also improving on vaccine delivery features related to the health care environment which parents 
believed to be superior in doctors’ offices. Pharmacists could potentially increase access to 
HPV vaccination for parents and adolescents in states that allow pharmacists to immunize 
adolescents. 
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CHAPTER ONE. OVERVIEW AND SPECIFIC AIMS 
 
 
Widespread uptake of human papillomavirus (HPV) vaccine could prevent thousands of 
cases of anogenital cancers, including cervical, vulvar, anal, penile, and possibly oropharyngeal 
cancers. As of 2014, only 40% of girls and 22% of boys ages 13 to 17 have completed the 3-dose 
HPV vaccine series. This coverage is markedly lower than coverage for other adolescent 
vaccines in the United States1 and is well below the Healthy People 2020 goal of 80% for 
teenagers ages 13 to 15.2 The underuse of HPV vaccine has been the target of many studies and 
interventions aimed at improving immunization rates. In 2014, the President’s Cancer Panel 
recommended expanding HPV vaccination to complementary medical settings, including 
pharmacies.3 More recently in 2015, the National Vaccine Advisory Committee also supported 
pharmacist-provided HPV vaccination,4 recognizing that pharmacists and pharmacies can play 
an important role in improving access to and opportunities for adolescents to obtain HPV 
vaccine.  
To date, most empirical research on pharmacy provision of HPV vaccine, and more 
broadly pharmacy provision of adolescent vaccines, has been limited to investigating policy 
issues regarding pharmacist authority to provide HPV vaccine, and parents’ attitudes toward 
obtaining the vaccine in this setting, such as comfort with and support of vaccinations in 
pharmacies or by pharmacists.5,6 These previous studies, however, have not examined explicitly 
how pharmacies can improve their utility as vaccination settings within American communities. 
Thus, in order to make pharmacies more viable as alternative settings for the provision of HPV 
    
	
2 
and other adolescent immunizations, more work is needed to understand the intrapersonal, 
provider, and structural factors related to pharmacies as vaccination settings that might motivate 
parents to obtain pharmacist-provided HPV vaccinations for their children. Evidence of these 
factors that characterize pharmacies as safe and appropriate adolescent vaccination settings 
would, in turn, greatly inform evolving health care policies around pharmacy practice that look 
to expand the pharmacist’s role in cancer care and prevention. Thus, my dissertation has the 
following aims: 
 
Aim 1. Establish the role of pharmacy type in parents’ willingness to get their children 
HPV vaccine from pharmacists. 
One unstudied area of pharmacy provision of HPV vaccine is how the type of pharmacy 
that a family typically visits may affect a parent’s willingness to obtain HPV vaccine for their 
child from a pharmacist. Most research on parents’ intentions or vaccination behaviors in 
alternative vaccination settings has categorized all pharmacies as a single type of setting but has 
not accounted for the various types of pharmacy that exist (e.g., chain drug store or local 
independent pharmacy). Thus, it is unclear how the type of pharmacy that a family frequents 
may affect a parent’s willingness to obtain HPV vaccine for their child in that setting. 
Additionally, linking the intervening attitudes and emotions associated with a type of pharmacy 
to parents’ willingness has not been explored. Marketing research has shown that perceptions of 
service quality and service satisfaction that are associated with a business correlate with purchase 
intentions of goods and services,7 an extension of the appraisal, emotional response, and coping 
framework described by Lazarus.8,9 As such, these services constructs may be associated with 
parents’ willingness to get their children HPV vaccine from a pharmacist. Accounting for the 
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variability in pharmacy type and parents’ impressions of service quality and satisfaction may 
help pharmacies improve their vaccination services. Moreover, the application of these services 
constructs will be a novel approach to understanding possible cognitive and emotional processes 
that may motivate behavioral intentions regarding HPV vaccination. 
 
Aim 2. Identify whether perceived advantages of vaccine delivery in pharmacies over 
doctors’ offices predict parents’ willingness to get their children HPV vaccine from a 
pharmacist. 
A second important but unstudied area is how pharmacies compare to primary care 
clinics as vaccination settings. Research suggests that parents prefer getting HPV vaccine for 
their children at doctors’ offices. However, no studies have examined whether different features 
of vaccination services, such as convenient hours and privacy, may lead parents to choose a 
pharmacy or a doctor’s office as a superior vaccination setting. Clarification of the provider 
characteristics that differ between pharmacies and doctors’ offices and how they are associated 
with vaccination willingness may enable pharmacies to better align their services to meet 
parents’ expectations in adolescent vaccine provision. 
 
Aim 3. Establish whether pharmacists can improve vaccine provider rates in areas with 
primary care shortages. 
A third understudied area is how pharmacists can address geographic disparities in HPV 
vaccination coverage. Previous research suggests that pharmacists are more frequently located in 
areas with poor access to health care resources than are primary care physicians.10,11 Preliminary 
findings from the UNC Adolescent Vaccinations in Pharmacies (AVIP) study suggest that 
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parents live closer to pharmacies than to their children’s doctors’ offices. Providing empirical 
evidence that pharmacies could potentially alleviate primary care access issues in areas could 
direct the development of public health interventions to improve vaccination rates in locations 
that can be considered “health care deserts”. Additionally, a geographic study assessing access to 
health care settings can help inform state pharmacy practice policies intended to expand 
pharmacist-provided HPV vaccination. 
  








In this literature review, I give a broad overview of HPV vaccine and pharmacy vaccine 
provision. I first review the public health significance of HPV infections and vaccination. 
Second, I give a summary of trends of HPV vaccine and other adolescent vaccines in the United 
States. Third, I provide a rationale for why pharmacies may be a more promising setting for 
vaccine delivery, and characterize the level of support that has been given to pharmacist-
provided HPV vaccinations. I conclude with the current state of HPV vaccination and other 
adolescent vaccinations research in pharmacies.  
 
PUBLIC HEALTH SIGNIFICANCE OF HPV VACCINATION 
 HPV is the most common sexually transmitted infection in the United States.12 
Approximately 79 million Americans are currently infected with HPV, and an estimated 14 
million people become newly infected each year.13 The prevalence of HPV infections is highest 
among younger females, with 25% of girls ages 14 to 19 and 45% of women ages 20 to 24 
infected,14 while estimates for males vary substantially from study to study.15 Over 40 distinct 
types of HPV can infect the genital tract, but around 90% of infections are self-limiting and 
resolve in two years.16 However, persistent infection with high-risk subtypes causes an estimated 
360,000 new cases of genital warts3 and 26,900 new cancer cases17 each year (anal, cervical, 
oral-pharyngeal, penile, vaginal, and vulvar cancers). An estimated 11,700 deaths occur each 
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year due to HPV-related cancers based on cancer-specific death estimates from the American 
Cancer Society18 and an assessment of HPV types in cancers.19 Direct medical costs associated 
with preventing and treating HPV-related diseases amounts to $8 billion annually.20  
 In 2006, the Food and Drug Administration (FDA) approved a three-dose quadrivalent 
HPV vaccine that protects against four common subtypes of HPV (6, 11, 16, and 18), conferring 
immunity against invasive HPV infections that cause 90% of genital warts and 64% of HPV-
related cancers.21 More recently in 2015, the FDA approved a nine-valent vaccine that protects 
against five additional subtypes (31, 33, 45, 52, and 58) conferring immunity to infections that 
cause an additional 10% of HPV-related cancers in men and women.22 The Advisory Committee 
on Immunization Practices recommends routinely vaccinating all adolescents ages 11 to 12 with 
the three dose series of HPV vaccine.21 Catch-up vaccinations are recommended for females up 
to age 26 and for males up to age 21.21  
 HPV vaccine has proven to be safe since its approval in the United States, and studies on 
its effectiveness have shown promising results. From 2006 to September 2015, more than 86 
million doses of HPV vaccine were administered in the United States.21 Randomized controlled 
trials23 and post-licensure data21 have shown no major side effects attributed to HPV vaccination. 
While long-term effectiveness of HPV vaccine in preventing cancer incidence is yet to be 
demonstrated, studies have shown the vaccine to be highly effective at reducing HPV 
infections,23-27 genital warts,24,26,27 and precancerous lesions.25,28 One study of Australian females 
less than 21 years old documented a reduction in the prevalence of genital warts by 93% by 2011 
after the introduction of a nationalized HPV vaccination program in 2007.26 A more recent study 
conducted in the United States showed a 56% reduction in the prevalence of vaccine-type HPV 
among young females ages 14 to 19.27 While fewer studies have been conducted in males, one 
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large, multinational trial exhibited the vaccine’s efficacy in preventing HPV infections in a 
sample of males ages 16 to 26.25  
 Despite HPV vaccine’s apparent benefits, vaccination coverage remains low in the 
United States. The most recent coverage estimates from 2014 show that HPV vaccine series 
completion is around 40% for girls and 22% for boys ages 13 to 17.1 Suboptimal vaccination 
leaves millions of adolescents exposed to preventable HPV infections and HPV-related diseases, 
signaling the need to address this important public health problem. 
 
ADOLESCENT VACCINATION PATTERNS IN THE UNITED STATES 
 HPV vaccine is part of an adolescent immunization schedule that also includes tetanus, 
diphtheria, and acellular pertussis (Tdap) booster and meningococcal vaccines, all of which are 
recommended for routine vaccination for adolescents starting at age 11 or 12.29 The U.S. 
Department of Health and Human Services created coverage objectives for these three vaccines 
as part of the Healthy People 2020 initiative, targeting coverage at 80% for adolescents ages 13 
to 15.2 As of 2014, Tdap booster and meningococcal national vaccine coverage are at 88% and 
79% respectively among 13 to 17 year olds,1 demonstrating rates that have either surpassed or 
are close to the Healthy People 2020 benchmark for adolescent ages 13 to 15. These data show 
that national HPV vaccine coverage is consistently lower than national coverage of Tdap and 
meningococcal vaccines. In spite of relatively good national coverage for Tdap and 
meningococcal vaccines, substantial variation exists among US states in coverage of all three 
vaccines among adolescents ages 13 to 17. Tdap vaccine coverage ranges from as low as 71% 
(Mississippi and Idaho) to as high as 95% (Connecticut).1 Meningococcal vaccine coverage is far 
more variable, from as low as 46% (Mississippi) to as high as 95% (Pennsylvania).1 HPV 
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vaccine series completion is the lowest, ranging from 20% (Tennessee) to 57% (Washington 
D.C.) for girls, and 9% (Alabama) to 43% (Rhode Island) for boys.1  
Variable vaccine uptake by state may, in part, be explained by lower health care use 
patterns among adolescents. Although studies show that adolescents have increased their use of 
preventive health services over the past two decades, all these studies point to a large percentage 
of adolescents not routinely attending at least one preventive health care visit with a primary care 
provider.30-32 The CDC recommends addressing these missed opportunities to vaccinate 
adolescents by co-administering multiple vaccines at one visit, known as concomitant 
vaccination, and immunizing during acute care visits in addition to preventive health care 
visits.33 CDC researchers suggest that if the first dose of HPV vaccine were administered when 
other adolescent vaccines were given, series initiation would be around 93% for 13 to 17 year 
old girls,33 and similar estimates possibly achievable for boys. However, completion rates could 
continue to lag due to the need for additional visits in order to complete the vaccine series. As a 
result, interest in alternative vaccination settings (i.e., settings outside of traditional primary care 
clinics) and their utility in the effort to improve HPV vaccine uptake has increased. In a recent 
review of alternative vaccination settings that I co-authored, pharmacies have been identified as 
the one of the most promising locations to improve access to and opportunities for HPV 
vaccinations.34  
 
VACCINATION IN PHARMACIES 
 Vaccination in community pharmacies has become commonplace in the United States. 
The pharmacy profession has over 20 years of experience providing vaccinations.35 Currently, all 
50 states and Washington D.C. allow pharmacists to immunize.36 As a result, pharmacists have 
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played an increasingly large role in vaccination services, particularly for adult populations. The 
American Pharmacists Association report that consumers make an estimated 250 million visits to 
pharmacies each week.37 The National Association of Chain Drug Stores estimates that 93% of 
U.S. residents live within five miles of a community pharmacy,38 demonstrating that pharmacists 
have tremendous reach within American communities. As of 2014, there are 297,100 licensed 
pharmacists,39 and among those, an estimated 50% are community pharmacists practicing in 
39,000 chain and over 23,000 independently owned community pharmacies located across the 
United States.38 Evidence also shows that pharmacists are able to reach medically underserved 
populations40,41 in addition to the healthy populations or those with easier health care access. 
This makes pharmacists one of the most accessible health care providers in the United States.  
Over these two decades, pharmacies have successfully implemented high-volume and 
efficient vaccination programs across the country. Twenty percent of adults received their 
influenza vaccine from a chain or supermarket pharmacy during the 2011-2012 flu season, an 
increase from 18% during 2010-2011 flu season.42,43 A recent study from one large pharmacy 
chain delivered over 6.2 million vaccine doses to adults over a course of a year.44 Another local 
pharmacy chain in Virginia developed an immunization program, and between 1998 and 2007, 
has delivered over 200,000 vaccines, including 2,500 immunizations to children, of whom over 
90% were uninsured.10 Additionally, a study of California pharmacies found that adult 
vaccination at pharmacies were provided at a lower unit cost (e.g., labor, materials, and overhead 
expenses associated with vaccinating a single patient) and more likely to be consistent with 
ACIP guidelines than vaccination in primary care settings.45  
Researchers have also noted other additional benefits of going to pharmacies over 
primary care clinics for vaccinations, namely convenient hours and ease of access.44,46-48 For 
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instance, Goad and colleagues found that among the 6.2 million vaccine doses administered at a 
large chain pharmacy, almost a third of all doses were provided during hours primary care clinics 
were typically closed.44 Another study in West Virginia looking among rural population found 
that convenience of vaccination hours and location of the pharmacy were the two most predictive 
factors in participating in a pharmacy immunization program.47 Additionally, patients generally 
do not need to make an appointment in advance, and in most cases have little or no wait time to 
get vaccinated.49 Moreover, the majority of pharmacies do not charge visitation fees that 
commonly occur in primary care settings.49 Pharmacists are also consistently ranked as one of 
the top three most honest and trusted professionals in the United States, below nurses and above 
physicians,50 which may also add to their appeal among many patients as immunizers. The 
established success of pharmacy vaccination services, along with easy access to pharmacies in 
the surrounding communities, have lead researchers to believe pharmacies may be an ideal 
location to expand adolescent vaccinations, especially HPV vaccinations. 
 
SUPPORT FOR PHARMACY-LOCATED ADOLESCENT VACCINATION 
 Over the past decade, several organizations, committees, and panels have taken positions 
on pharmacy’s role in adolescent vaccinations more broadly, and, in recent years, specific to 
HPV vaccination. Pharmacists’ scope of practice has been a continual concern for medical 
organizations, chiefly those representing pediatricians and family medicine physicians, 
specialties that provide the vast majority of care to adolescents. Many primary care physicians 
are not comfortable with adolescent immunizations, especially HPV vaccination, in pharmacies, 
arguing that stand-alone services will encourage parents to have fewer comprehensive primary 
care visits for their adolescent children.51 As a result, medical organizations take positions that 
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reaffirm physicians as the primary, and preferable source of all preventive care for pediatric 
patients, preferring pharmacists play a limited role in pediatric preventive care.  
One of the earliest to take a position was the American College of Physicians in 2002, 
who supported pharmacists in their role as vaccine educators, facilitators, and immunizers, “as 
appropriate and allowed by state law”.52 The Society of Adolescent Medicine in 2006 endorsed 
the use of pharmacies as a possible alternative setting for adolescents who are unable to access 
preventive health services to get vaccines, arrange referrals for adolescents to primary care 
providers to get recommended vaccines, or to furnish vaccine educational materials appropriate 
for adolescents.53 In 2010, the American Academy of Pediatrics (AAP) gave limited support for 
pharmacy-located adolescent vaccinations as state pharmacy practice laws allow it, supporting 
pharmacist to provide vaccine only if patients have unreliable access to a primary care clinic;54 
although, they have generally continued to oppose expanding pharmacists’ role in vaccination. 
AAP and the American Academy of Family Physicians have both lobbied against expanding 
pharmacy-based immunization practices to include adolescent vaccinations, especially HPV 
vaccine.55 While the concern that pharmacy-based vaccinations would undermine the patient-
centered medical home is well intentioned, no evidence supports this concern. Preliminary 
findings from the Adolescent Vaccination in Pharmacies survey, a national study of parents of 
adolescents ages 11 to 17, found that only seven percent of parents disagreed that they would 
take their child to a physician just as often if given the opportunity to get their child vaccinated 
from a pharmacist (unpublished). 
Federal groups, panels, and committees have taken positions that are more supportive of 
expanding adolescent vaccination to pharmacies. Schaffer and colleagues as part of a CDC 
working group published a report in 2008 evaluating the capacity and readiness of several 
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vaccination settings outside the traditional medical home to vaccinate adolescents, and concluded 
that pharmacies were well-suited within the National Vaccine Advisory Committee’s quality 
standard.35 In 2014, The President’s Cancer Panel made recommendations to expand HPV 
vaccination to complementary medical settings such as pharmacies in an effort to expand access 
to HPV vaccine, and ultimately help vaccine uptake.3 Most recently in 2015, the National 
Vaccine Advisory Committee (NVAC) provided further support for pharmacist-provided HPV 
vaccination, identifying pharmacists and pharmacies as important to providing further access to 
and opportunities for adolescents to get HPV vaccine.4 As a result, the growing national interest 
in pharmacies has caught the eye of research to better understand the role of pharmacies in 
adolescent vaccinations, particularly for HPV vaccination.  
 
HPV VACCINATIONS IN PHARMACIES 
 Research on pharmacy-located HPV vaccination has largely focused on policy issues 
involving pharmacist vaccination authority,56,57 prevalence of vaccinations,58,59 or support and 
comfort with pharmacies as a vaccination setting for adolescent vaccines generally,58,60 or HPV 
vaccine specifically.5,6 As of 2015, 47 states allow pharmacists to administer HPV vaccine, but 
their degree of autonomy to vaccinate adolescents varies greatly.61 For instance, 43 states allow 
pharmacists to vaccinate adolescents as young as age 18, but only 23 states allow pharmacists to 
vaccinate adolescents as young as age 12.61 Additionally, state pharmacy practice statutes that 
dictate the process by which pharmacists may administer vaccines vary substantially, with some 
states allowing pharmacists to provide vaccines with independent authority and others restricting 
vaccination pursuant to a prescription from a primary care provider.57 Despite the substantial 
variability in pharmacist authority to provide HPV vaccine, it is likely many pharmacists would 
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be interested in administering HPV vaccine to adolescents if authority was expanded. A survey 
of North Carolina pharmacists found that nearly two-thirds of pharmacists were supportive of 
pharmacy immunization expansion to include HPV vaccination.56  
 Prevalence of adolescent vaccinations in pharmacies is likely to be very low at present, 
and no precise national estimates are publicly available. In a 2009 survey of state pharmacy 
association directors, less than 25% reported that pharmacies routinely carried adolescent 
vaccines (defined as Tdap, HPV, meningococcal, and Hepatitis B vaccines) in their states, 
whereas over 50% routinely carried influenza vaccine.59 In another 2010 survey of mostly racial 
and ethnic minority parents living in a large urban setting, around 5% had their adolescents ages 
11 to 14 immunized at a pharmacy for any adolescent vaccine.58 In a third study, 6,790 doses of 
HPV vaccine were administered to adults (³ 18 years old) during off-peak hours over a 12 month 
period at a large pharmacy chain, representing about .1% of all vaccine doses given to adults at 
that pharmacy.44 Personal correspondence with the same large pharmacy chain revealed that for 
the 2014 calendar year, 3,032 HPV vaccine doses were provided nationally to adolescents ages 
11 to 17 (unpublished), supporting the assumption of very low use of pharmacies for HPV 
vaccination. While the number of pharmacies carrying adolescent vaccines may have increased 
since 2009, the stark contrast between the availability of adolescent vaccines versus influenza 
vaccine and the number of adolescent vaccines reportedly administered indicate low demand 
among parents for adolescent vaccination, limited awareness of adolescent vaccination services 
at pharmacies that would not warrant larger vaccine supplies, or slow diffusion of a novel health 
care service.  
Support or comfort among parents to get any adolescent vaccine at a pharmacy tends to 
be lower compared to support of or comfort with primary care clinics, but still significant. In one 
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study, parents who lived in rural compared to urban areas were more likely to find vaccination 
settings outside of the medical home, including pharmacies, as the best setting for adolescent 
vaccination.60 In addition, over one third of parents were accepting of getting their children 
vaccinated in a pharmacy.60 This may point to the utility of pharmacies for parents who live in 
areas with limited access to preventive health services. However, these studies are limited in that 
they examined HPV vaccine jointly with other adolescent vaccines, making it difficult to 
determine whether the level of comfort with HPV vaccination in pharmacies is similar to other 
vaccinations. 
  Two studies have examined correlates of comfort with pharmacies as a vaccination 
setting among parents and their adolescent sons.5,6 In both studies, parents whose sons did not 
have a recent health care visit were more comfortable with using pharmacies as compared to 
parents whose sons did have a recent health care visit. Additionally, one of the studies showed 
that previous use of alternative settings, and higher perceived barriers to getting HPV vaccine 
were positively correlated with comfort with using pharmacies and other alternative settings.6 
These findings also point to the possible benefit of pharmacies reducing barriers to HPV 
vaccination for hard-to-reach adolescents. However, these studies are limited in that the samples 
did not include parents of adolescent girls. 
 
GAPS IN PHARMACY-LOCATED HPV VACCINATION RESEARCH 
While the studies previously described provide formative research in our understanding 
of pharmacy-located HPV vaccination, large gaps in our knowledge hinder our ability to inform 
future public health research and health policy aimed at using pharmacies as adolescent 
vaccination settings effectively. First, all the studies categorize pharmacies as a single type of 
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setting and do not account for the various pharmacy types that exist (e.g., chain drug store, local 
independent pharmacy). Thus, it is unclear how the type of pharmacy may affect a parents’ 
willingness to obtain HPV vaccine for their children in that setting. If engagement in HPV 
vaccination service is influenced by the pharmacy type, this could help current pharmacies to 
align their business practices to make themselves more appealing to parents’ preferences.  
Second, research shows that parents prefer going to a primary care clinic to get their 
children HPV or other vaccine as opposed to going to pharmacies.5,6,58,60 However, no studies 
have examined how different features of vaccination services, such as convenient hours and 
privacy, may lead parents to choose a pharmacy over a doctor’s office as a superior vaccination 
setting, or vice versa. Understanding the features that influence a parent’s willingness will 
provide further insight on how pharmacies can meet parents’ expectations in the vaccination 
experience.  
Lastly, no studies have examined whether pharmacies, a setting identified for having 
convenient locations in neighborhoods, could alleviate geographic disparities in HPV 
vaccination coverage. Research reviewed in this chapter suggests that pharmacies could play a 
role in improving access to HPV vaccinations. Previous studies have shown geographic 
variations in HPV vaccination coverage,62,63 and these geographic variations may be in part due 
to unequal distribution of health care resources.63 If pharmacies could potentially alleviate 
primary care access issues in areas with poor vaccination coverage, the use of pharmacies as a 
vaccination outlet could direct the development of public health interventions aimed to improve 
vaccination rates, and help inform state pharmacy practice policies intended to expand 
pharmacist-provided HPV vaccination. 
  




 HPV vaccination rates are too low, stifling its potential to prevent thousands of cancer 
cases in the coming years. Expanding access of HPV vaccination to pharmacies may help 
improve vaccination rates and reduce geographic disparities. However, in order to do this, 
engagement with pharmacies as a vaccination setting needs to increase. More research is needed 
to understand how pharmacies can improve as a vaccination setting to increase demand for 
pharmacist-provided vaccinations among parents, and whether they can alleviate low vaccination 
rates in areas with poor access to preventive care.




CHAPTER THREE. RESEARCH AIM ONE: PHARMACY TYPE’S RELATIONSHIP 
WITH HPV VACCINATION WILLINGNESS 
 
OVERVIEW 
 This chapter focuses on Aim One of my dissertation. I begin by explaining the theoretical 
relationship among service quality, satisfaction, and purchase intentions and their operational 
definitions. I then give a brief overview of how service setting may influence service quality. 
Third, I present a conceptual model for how pharmacy type may impact HPV vaccination 
willingness, my hypotheses for the proposed relationships among the study constructs, and the 
study’s implications. Next, I present an overview of the data source and procedures. Fifth, I go 
over the analytical approaches I plan to use to test my hypotheses. I conclude the chapter with a 
discussion of strengths and limitations of the proposed research aim. 
 
SERVICE QUALITY, SATISFACTION, AND PURCHASE INTENTIONS 
 Attitude theories such as theory of reasoned action and theory of planned behavior have 
proven versatile in conceptualizing a wide realm of social behaviors.64 However, researchers 
have noted that self-regulatory processes (e.g., monitoring, appraisal, and coping) are important 
in turning attitudes into intentions, and ultimately intentions into actions.65 As such, many 
researchers have looked to characterize the link between attitudes and intentions, particularly in 
marketing research which is principally preoccupied with increasing customer engagement.  
Marketing research has shown that a firm’s performance has been closely tied to 
improving customer perceptions of service quality and feelings of satisfaction. Understanding the 
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intricacies of how customer perceptions develop allows companies to leverage their relative 
advantages in competitive markets, ultimately increasing customer engagement with their 
products and services.66 Marketing research over the past three decades has aimed to characterize 
the underlying cognitive process that strengthens behavioral intentions for customer engagement, 
specifically purchase intentions for existing or novel products and services.66 This has relevance 
for pharmacies that intend to improve on established health services (e.g., medication dispensing, 
counseling), or engage customers in new services (e.g., HPV vaccinations for adolescents). One 
widely used framework used to understand the roles of the different services constructs, namely 
perceived service quality and customer satisfaction, was first developed by Lazarus, and then 
further advanced by Bagozzi. 
 Framework for emotion and adaptation. Lazarus’ appraisal, emotional response, and 
coping framework8 formed the foundation of the current understanding of purchase intentions. 
The framework begins with an appraisal; a person first establishes the significance of an actual 
or hypothetical event (primary appraisal) and then assesses his or her ability to cope with the 
consequences of that event (secondary appraisal).9 Once a person has established the significance 
of the event and the resources available to cope with it, he or she will then have an emotional 
response (e.g., anger, guilt, anxiety, sadness).9 The resulting emotional response will cause a 
person to cope, or adapt, to the environmental stimulus that caused the situational appraisal and 
emotional response.9 Lazarus used this framework mostly as it applied to physiological or 
psychological stress. The transactional model of stress and coping builds on Lazarus’ theoretical 
work, and has been applied to various environmental stressors such as racism and socioeconomic 
status, and individual stressors such as chronic diseases like cancer and HIV/AIDS.67 Bagozzi 
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also applied Lazarus’ framework to explain how attitudes may be linked to behavioral intentions 
to contexts and outcomes of interest in marketing research. 
 Self-regulation of attitudes and intentions. Bagozzi criticized contemporary attitude 
theories (e.g., theory of reasoned action, theory of planned behavior), arguing that subjective 
norms and attitudes are not sufficient predictors of behavioral intentions, and aimed to address 
the relevance of cognitive and emotional self-regulatory processes that may mediate the effect of 
subjective norms and attitudes on behavioral intentions.65 Similarly to Lazarus, Bagozzi 
proposed that attitudes were evaluative appraisals which he named “outcome-desire units” 
(Figure 3.1). A person engages in an activity because he or she looks to achieve a particular goal 
or outcome (e.g., purchase a product). An outcome can either be unattained (outcome desire 
conflict) or achieved (outcome desire fulfillment) which leads to an affective response 
(emotional reactions). As a result, a person will begin a coping response (e.g., maintain or 
increase purchase intentions). Marketing researchers have used this theoretical framework to 
evaluate the relationships among perceived service quality, satisfaction, and purchase 
intentions.7,66,68-71  
 Service quality and satisfaction. Service quality is conceptualized as “the consumer’s 
overall impression of the relative inferiority/superiority of organizations and their services.”72 
Service quality within the previously discussed frameworks operationalizes as an attitude, since 
the construct encompasses an appraisal process judging a service as either favorable (outcome-
desire fulfillment) or unfavorable (outcome-desire conflict). Satisfaction is conceptualized to be 
a distinct construct from perceived service quality in that it is “a summary of cognitive and 
affective reaction to a service incident (or sometimes to a long term service relationship).”73 
Therefore, satisfaction is an emotional response that develops from a service incident or long-
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term service relationship. As a result of this emotional response, satisfaction (or dissatisfaction) 
is theorized to have a direct influence on an individual’s purchase intentions. Empirical research 
supports perceived service quality and satisfaction as two separate constructs,72 and support the 
relationship between the services constructs and purchase intentions as causally linked: increases 
in perceived service quality leads to increases in satisfaction, which leads to stronger purchase 
intentions.7,66,68-71  
 
MEASURING PERCEIVED SERVICE QUALITY IN DIFFERENT SERVICE 
SETTINGS 
 Perceived service quality varies substantially based on the context in which firms provide 
services. The rationale for this is that customers’ perceptions of service quality have several 
dimensions that manifest themselves as customers engage with a service at a firm,74-76 and 
certain dimensions of service quality may be more salient to a particular product and service or 
organization type.77 The most widely used measure for perceived service quality has been 
SERVQUAL, a five-factor scale developed by Parasuraman, Berry, and Zeithaml.75 Parasuraman 
and colleagues originally defined service quality to have 10 components or constructs: reliability, 
responsiveness, competence, access, courtesy, communication, credibility, security, 
understanding/knowing the customer, and tangibles.74 Later, these constructs were empirically 
tested and distilled into five dimensions: reliability, tangibles, responsiveness, empathy, and 
assurance (definitions of dimensions in Table 3.1).75,76 The researchers looked to develop a 
“skeleton” measure that could be adapted to any service context.  
However, since the development of SERVQUAL, many researchers have criticized the 
scales’ generalizability to various service settings. For instance, Cronin and Taylor questioned 
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Parasuraman and colleagues’ original conceptualization of service quality as a gap between 
service performance and service expectations.7 Cronin and Taylor found that a scale that just 
focused only on performance-based measures (called SERVPERF) explained more of the 
variance observed in four service industries (banking, pest control, dry cleaning, and fast 
food).7,78 A study conducted by Lee and colleagues 10 years later in South Korea also found the 
performance-based measures outperformed the original SERVQUAL measure.79 Additionally, 
several researchers have noted that the stability of the SERVQUAL dimensions were highly 
service context dependent, and certain dimensions may play a more significant role than others 
depending on the service and industry.77-81 As a result, when measuring service quality for a 
certain industry, researchers should take extra care to understand the underlying criteria 
customers may use to evaluate service quality, and adapt scales, particularly the SERQUAL 
measure, to reflect the dimensions of this attitude. 
Service quality in pharmacies. As pharmacies have progressively moved away from 
product driven businesses to more service oriented practices, service quality scales should reflect 
this shift when attempting to accurately gauge a customer or patient’s perceptions. Hedvall and 
Paltschik operationalize SERVQUAL’s original 10 constructs as they pertain to a customer’s 
perceived service quality in a pharmacy that is more service oriented (Table 3.2; construct 
definitions found in Appendix I).82 Their definition of perceived service quality can be 
operationalized as a customer’s appraisal of the commitment, confidentiality and professionalism 
of the pharmacist, and the milieu of the pharmacy.82 Since the commitment dimension is defined 
to be oriented towards a specific product purchased rather than engagement with a future service 
(e.g., HPV vaccination), I will use a modified definition of perceived service quality as a 
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customer’s appraisal of the confidentiality and professionalism of the pharmacist, and the milieu 
of the pharmacy. 
 
RESEARCH QUESTIONS 
Pharmacies as a health care setting can vary substantially in appearance and range of 
services. As discussed in Chapter Two, pharmacies have mostly been studied as one category 
among several other kinds of alternative vaccination settings for adolescents. In reality, several 
types of pharmacies exist, including chain pharmacies (e.g., CVS and Walgreens), local-
independently owned pharmacies, and pharmacies located in medical practices and hospitals. To 
the best of my knowledge, no empirical evidence has been published on the association of 
pharmacy type on a parent’s willingness to get his or her child HPV vaccine from a pharmacist. 
While pharmacists and pharmacy businesses have been providing adult vaccination services for 
over two decades, adolescent vaccine provision is a relatively new service for this health 
profession. Customer perceptions of service quality and their satisfaction are established 
predictors of customer engagement with existing and new services in other industries. 
Understanding the impact of perceived service quality and satisfaction on a parents’ willingness 
to get HPV vaccine from a pharmacist may provide direction for how pharmacies can better 
align their business and clinical practice to appeal to parents’ expectations for vaccination 
services. As a result, I propose the following research questions for Aim 1: 
1. Is pharmacy type associated with a parent’s willingness to get his or her child HPV 
vaccine from a pharmacist? 
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2. Do dimensions of perceived service quality at a pharmacy and overall satisfaction with 
the health services at a pharmacy mediate the relationship between pharmacy type and 
willingness to get HPV vaccine? 
3. How do the dimensions of perceived service quality at a pharmacy and overall 
satisfaction of health services at a pharmacy mediate the association between pharmacy 
type and willingness to get HPV vaccine? 
 
CONCEPTUAL MODEL AND HYPOTHESES 
 Pharmacy type’s impact on HPV vaccination willingness. My conceptual model draws 
upon the theoretical framework developed by Lazarus8 and Bagozzi,65 and the operationalization 
of perceived service quality by Hedvall and Paltschik (Figure 3.2).82 The central component of 
this study is the relationship between pharmacy type (defined as a chain or non- chain 
pharmacies) and a parent’s willingness to get his or her child HPV vaccine from an immunizing 
pharmacist.  
There is currently no evidence on how pharmacy type has an impact on a parent’s 
willingness to get HPV vaccine. Anecdotal evidence suggests that parents who usually go to 
independent pharmacies or pharmacies located in clinics or hospitals (i.e., non- chain 
pharmacies) may have higher willingness to get HPV vaccine for their children at these locations 
compared to parents who go to pharmacies like CVS or Kroger (i.e., chain pharmacies). This 
may be due to greater intimacy parents feel at these pharmacy locations compared with chain 
pharmacies. Thus, I first hypothesize that: 
Hypothesis 1. Parents who go to non-chain pharmacies have higher willingness to get their 
children HPV vaccine from a pharmacist than parents who go to chain pharmacies. 
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Mediation.  Bagozzi’s framework suggests that some pharmacies can strengthen parents’ 
willingness to get HPV vaccine (i.e., strengthen purchase intentions) by increasing parents’ 
perceptions of service quality and satisfaction. This conceptual model includes four distinct 
mediators, three comprising service quality perceptions and one comprising overall satisfaction 
with health services at the pharmacy. 
The first two mediators, professionalism (i.e., having the customer’s best interest at heart 
and performing the duties of the pharmacist promptly and accurately) and confidentiality (i.e., 
creating an atmosphere enabling customers to feel that they are cared for and enabling them to 
feel free to discuss problems and ask questions) may play a role on how pharmacy type exerts its 
effect on satisfaction.82 Parents may evaluate their interpersonal interactions with pharmacists, 
judging how attentive and caring they are to requests, or how easily they can talk about sensitive 
health problem. Similarly, the third mediator, milieu (i.e., the physical premises of the 
pharmacy), may intervene on the effect pharmacy type has on satisfaction by parents evaluating 
the physical space as appropriate for certain types of health services, or generating impressions 
of how accessible the pharmacy is during operating hours. Thus, parents who go to independent 
pharmacies or pharmacies located in clinics or hospitals (compared to chain pharmacies) may 
have more favorable perceptions of the pharmacist’s professionalism and confidentiality, and 
more favorable perceptions of the pharmacy’s milieu, leading to higher overall satisfaction, 
resulting in higher willingness to get their children HPV vaccine from pharmacists. Based on the 
previously described theory and empirical research conducted in other service settings, I 
hypothesize: 
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Hypothesis 2. The effect of pharmacy type on parents’ willingness to get their child HPV 
vaccine from a pharmacist will be mediated by the three service quality appraisals and overall 
satisfaction with health care services at the pharmacy. 
 Hedvall and Paltschik suggest in their evaluation of the four service quality dimensions 
that professionalism and milieu are the two factors of service quality that are minimum 
preconditions for the services offered.82 Their empirical finding suggests that beyond fulfilling 
those two preconditions, pharmacists can provide “added value” by emphasizing 
confidentiality.82 In other words, it may be that appraisals of the pharmacist’s professionalism 
and the milieu of the pharmacy are more strongly associated with overall satisfaction than 
appraisal of a pharmacist’s confidentiality, leading to higher willingness to get HPV vaccine. 
Based on this finding, I will explore whether the mediated paths between pharmacy type and 
parents’ willingness to get HPV vaccine that include perceived professionalism and milieu will 
be more positively correlated than the mediated path that includes perceived confidentiality. 
 
SIGNIFICANCE AND IMPLICATIONS OF THE STUDY 
This study may be one of the first theoretical contributions to evaluating pharmacy’s 
utility in adolescent vaccination services. Exploring the mediators of the association between 
pharmacy type and parents’ willingness to get their children HPV vaccine from a pharmacist can 
help pharmacies pinpoint how to engage established and new patients to participate in new 
adolescent vaccination services, ultimately making HPV vaccine provision in pharmacies a 
viable alternative to the traditional medical home or other vaccination setting. A deeper 
understanding of the processes through which pharmacy type influences willingness to vaccinate 
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can inform the design of new or revised pharmacy practice models that capitalize on parent’s 
perceptions of what they deem as quality health services. 
 
OVERVIEW OF DATA SOURCE AND PROCEDURES 
Data source: The Adolescent Vaccinations in Pharmacies (AVIP) Study. The AVIP study 
was an online survey of U.S. parents of adolescents conducted from November 2014 to January 
2015. Study participants were members of an existing, national panel of non-institutionalized 
adults maintained by a survey company.83 The national panel was created through probability-
based sampling of U.S. households using a combination of random-digit dial and addressed-
based sampling frames. Eligible respondents were parents of at least one child between the ages 
of 11 to 17 who lived with them at least half of the time. We focused on parents of children 
between ages 11 and 17 since recommendations for adolescent vaccines begin at age 11, and 
adolescents in this age range are still minors and, in most instances, need a parent’s permission to 
get vaccinated. Parents were asked to answer survey items thinking about their child, or one of 
their children, aged 11 to 17 they identified in the beginning of the survey. As incentives, the 
survey company provides a computer and free internet access to panel members from non-
internet households. Those panel members who have an existing computer and internet access 
get points for completing surveys that can be redeemed for small cash payments. 
The survey company sent email invitations to a random selection of 2,845 panel members 
who previously indicated they had at least one child between the ages 11 and 17. A total of 1,760 
parents responded by accessing the survey website, providing informed consent, and completing 
an eligibility screener. A total of 1,518 parents were eligible and went on to complete some 
portion of the survey. After we excluded 14 panel members for failing to answer more than one-
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third of survey questions, our final analytic sample consisted of 1,504 parents. Respondents 
included residents of all 50 states and Washington DC. Our overall response rate was 61.2%, 
based on the American Association for Public Opinion Research Response Rate 5 calculations 
for online probability-based panel surveys, which takes into account contacted panel members 
who were ineligible to participate (n = 389).84,85  
Measures for analyses & survey item development. Measures for Aim One analyses are 
located in Appendix 2. Survey items were developed based on previous research among parents, 
adolescents, and health care providers.86-90 Additional items for the AVIP survey were adapted 
from other sources.7,91,92 The AVIP survey instrument was cognitive tested with a convenience 
sample of 18 parents of adolescents ages 11 to 17 to ensure the clarity of survey items, and pre-
testing with 26 parents from the national panel to ensure proper survey functionality. The full 
AVIP survey instruments are available online at www.unc.edu/~ntbrewer/hpv.htm.  
HPV vaccination willingness. The outcome of interest for this study is willingness to get 
HPV vaccine from a pharmacist. Parents were first prompted with the statement “Imagine you 
and [child’s name] decided to get the HPV vaccine for [him/her].” Parents were then asked 
“How willing would you be to have [child’s name] receive it from an immunizing pharmacist?” 
Parents indicate the extent of their willingness as “definitely not willing” to “definitely willing” 
(coded 1-4). 
Service quality and satisfaction items. Parents were asked to respond to nine items about 
their perceptions of service quality and one item about their feeling of overall satisfaction at the 
pharmacy they usually go to for their children’s prescription medications. A parent was first 
asked to “think about the pharmacy you would usually go to if you needed to get [child’s name] 
prescription medications.” They then indicated what kind of pharmacy it is. This pharmacy type 
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variable will be recoded so that chain pharmacy, a pharmacy in a grocery store, and a pharmacy 
in a big box store (termed “chain pharmacies”) is the referent coded “0,” and a pharmacy in a 
clinic or hospital or an independent pharmacy (termed “non-chain pharmacies”) is coded “1.” 
Next, parents were asked the extent to which they disagreed or agreed with nine statements about 
their perceptions of service quality at this pharmacy (“strongly disagree” [1] to “strongly agree” 
[5]). Finally, parents were asked the extent to which they were dissatisfied or satisfied with the 
health services they receive at the pharmacy (“completely dissatisfied” [1] to “completely 
satisfied” [7]). 
Covariates. The survey company provided parent and household demographics including 
parent sex, age, race and ethnicity, education, as well as household income, urbancity, and U.S. 
region of residence. Additionally, the survey included questions that assessed parents’ beliefs 
and attitudes about adolescent vaccinations and who the primary health care decision maker is 
for the index child.  For demographic and health characteristics for the parent’s index child 
(reported by the parent), we assessed sex, age, race and ethnicity, perceived health status (five-
point response-scale ranging from “excellent” [1] to “poor” [5]), HPV and other adolescent 
vaccinations status, and previous use of an alternative vaccination setting (defined as having 
received a vaccine at a pharmacy, school, or health department). 
Missing data. Missing responses for any given survey item for this research aim is no 
more than 0.8%. Traditional methods for handling missing data such as listwise and pairwise 
deletion or mean substitution are no longer recommended due to these methods distorting 
standard errors, biasing parameter estimates, and reducing statistical power with respect to the 
deletion approaches.93 Instead, I will employ full information maximum likelihood (FIML) 
estimation, a preferred method by several leading methodologists.94-97 In situations of missing 
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data, FIML estimation determines parameter estimates by employing likelihood functions based 
only on the means, variances, and covariances of the variables on which the case has complete 
data, partitioning the data into subsets based on patterns of missingness. FIML estimation has 
advantages over multiple imputation (MI), another recommended method for handling missing 
data, in that it is more efficient than MI, it always produces the same results unlike MI, and it 
avoids potential conflicts that could arise between the analytic model and the MI model that is 
predicated on the multivariate normal distribution assumption.96 FIML estimation is available in 
several statistical packages, including Stata and Mplus (Los Angeles, CA). 
 
AIM ONE ANALYTIC APPROACH  
I will use Stata version 13.1 (College Station, TX) for data cleaning and variable 
recoding, descriptive statistics, and other basic analyses. I will conduct confirmatory factor 
analysis and structural equation modeling in Mplus 7.4. All hypothesis tests will use two-tailed 
tests with a critical alpha of 0.05.  
Confirmatory factor analysis of nine perceived service quality items. As I described 
earlier, I conceptualized perceived service quality as having three dimensions: professionalism, 
confidentiality, and milieu. For the purpose of this study, our scale development prioritized 
creating indicators that encapsulated professionalism, confidentiality, and milieu. We decided to 
not include the commitment dimension as this dimension was more oriented towards a specific 
product purchased, while our model was looking to engage parents in a future service (HPV 
vaccination). Candidate indicators can be found in Appendix II. I will conduct confirmatory 
factor analysis to evaluate the hypothesized factor structure, depicted in Figure 3. I will use 
maximum likelihood robust standard errors to account for data that are not likely multivariate 
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normally distributed. I will test CFA models to evaluate if my hypothesized model fits the data 
better than alternative models.98  
 I will first run separate measurement models for each latent variable (represented by 
ovals), which specify the hypothesized relationship among indicator variables and the latent 
factor. I will use several test statistics to evaluate model fit, including c2 statistics (p>.05), the 
root mean square error of approximation (RMSEA <.08 = acceptable; RMSEA<.05 = ideal),99 
the Bentler Comparative Fit Index (CFI>.90),100 and the Tucker Lewis Index (also known as the 
Non-normed Fit Index; TLI>.90).101 I will respecify the model using both theory and empirical 
tests (e.g., Bayes Factor derived from Bayesian Information Criterion) in order to improve fit if 
any of these statistics demonstrate that the model’s fit is not adequate.94,97 Finally, I will evaluate 
reliability of the factors using coefficient w (“omega”; w>.70). Coefficient w is a superior 
alternative for calculating scale reliability compared to Cronbach’s a (“alpha”) as w relaxes the 
assumption that all items in a single factor or scale are essentially tau equivalent.102 If the tau 
equivalent assumption is held, w will equal Cronbach’s a. 
Structural equation model for mediation analysis. I will use structural equation modeling 
(SEM) to evaluate my mediation hypothesis in Aim 1, following the analytic steps outlined by 
Bollen94 and Kline.97 SEM is a method for estimating causal structures among a set of latent (i.e., 
unobserved) variables, and it represents the integration of path analysis and confirmatory factor 
analysis (i.e., a simultaneous estimation of both structural and measurement models). SEM has 
advantages over other analytic approaches such as ordinary least squares (OLS). For instance, 
measurement error can be incorporated into the model, either by using multiple indicators for 
each latent variable or by setting the measurement error of a single indicator to some nonzero 
value indicating the proportion of measurement error in the measure. Another key advantage in 
    
	
31 
SEM is that measurement and structural parameters are estimated simultaneously using full-
information estimation procedures, and standard errors are concurrently generated for indirect 
and total effects.  
Similar to the analysis plan for the confirmatory factor analysis described earlier, I will 
use an iterative model building process and employ the same fit statistics described earlier to test 
model fit (e.g., RMSEA, CFI, and TLI). The final structural equation model will specify the 
relationship among the exogenous variable (pharmacy type), the latent variables 
(professionalism, confidentiality, milieu), and the measured variable for overall satisfaction, and 
the measured dependent variable of willingness to vaccinate. 
To test my hypotheses, I will first estimate a measurement model showing the 
relationship between pharmacy model and a parent’s willingness to get his or her child HPV 
vaccine from an immunizing pharmacist (Figure 3.4)  
Based on hypothesis 1, I predict that: 
§ Prediction 1: Non- chain pharmacies will be associated with higher willingness to get 
HPV vaccine from an immunizing pharmacist compared to chain pharmacies. Path c will 
be positive and significant. 
Once the direct path has been estimated, I will use the structural model depicted in Figure 3.5 
to estimate standardized path coefficients and p-values for Hypotheses 1.2. The pathways in 
SEM are similar in interpretation to traditional methods for mediation analysis.103 The product 
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Based on hypothesis 2, I predict that: 
§ Prediction 2: Non-chain pharmacies will elicit higher perceptions of service quality 
compared to chain pharmacies; a1, a2, and a3 pathways will each be positive and 
statistically significant. 
§ Prediction 3: Higher perceptions of service quality will be associated with higher overall 
satisfaction; d1, d2, and d3 pathways will each be positive and statistically significant. 
§ Prediction 4: Higher perceptions of overall satisfaction will be associated with higher 
willingness to get HPV vaccine from a pharmacist; b pathway will be positive and 
statistically significant. 
§ Prediction 5: Perceived service quality and overall satisfaction will mediate the 
relationship between pharmacy type and willingness to get HPV vaccine; each mediated 
pathway (a1*d1*b; a2*d2*b; a3*d3*b) will be positive and statistically significant. 
Alternative approach to examining mediation. If the proposed analytic approach using 
SEM does not work (i.e., the models do not converge), I will instead fit path models using 
ordinary least squares (OLS) regression. I will plan to use the PROCESS macro in SAS as an 




 SEM power calculations are different from those typically used for OLS. SEM power 
calculations take into account the structure of the model, and the hypothesized factor loading of 
observed variables on unobserved latent variables (e.g., the measurement model).106 Two 
calculations are necessary to determine the power needed for an SEM. First, the minimum 
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sample size needed for model structure derived from the ratio of observed to latent variables. 
Second, the sample size needed to detect the hypothesized effect derived from the correlation 
between any two latent variables and the desired minimum effect size. 
The specific power calculations used for this study is the lower bound sample size 
calculation for structural equal models:106 














6 − 3 + 4 + /
+	 0 16 − 3 + 4 + /
)
+ 40/ 16 +	 0 + 23 − 5 − 24  
 
0 = 1 −	6) 
 
3 = 	6arcsin 62  
 
5 = 	6arcsin 6  
 
4 =	 03 − 0 
 




Where "n1" refers to the sample size needed for model structure, "n2" refers to the sample size 
needed to detect the hypothesized effect between any two variables in the structural model, "j" is 
the number of observed variables, "k" is the number of latent variables, "ρ" is the estimated Gini 
correlation for a bivariate normal random vector between any two latent variables, "δ" is the 
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anticipated effect size, "α" is the Sidak-corrected Type I error rate, "β" is the Type II error rate, 
and "z" is a standard normal score.106,107 The sample “n” needed for sufficient power will depend 
on if n1 or n2 is larger.  
The hypothesized structural model has 14 observed variables and 3 latent variables. 
Based on a desired effect size > .05, desired statistical power > .8, and alpha = .05, I would need 
a minimum sample of 89 people to account for model structure (not including covariates as 
controls) and a minimum sample size of 1,172 people to estimate an effect size >.05. Minimum 
sample for model structure would increase to 1,423 if an additional 15 observed variables were 
added to the structural model (total = 29) as covariates. As a result, the study is sufficiently 
powered with an analytic sample of 1,504. 
 
STRENGTHS AND LIMITATIONS 
To the best of my knowledge, this will be the first study to empirically evaluate how 
pharmacy type is associated with parent’s willingness to get HPV vaccine from a pharmacist. 
Moreover, this study applies a theoretical model to understand possible cognitive and emotional 
responses that may motivate parents to get HPV vaccine and other adolescent vaccines at a 
pharmacy. Data from this study come from a national sample of U.S. parents of adolescents with 
a good response rate for online surveys. Additionally, I developed the survey items based on 
previous theoretical and empirical marketing research, and refined them based on feedback from 
pharmacy practice experts and cognitive interviews of parents of adolescents. A notable 
limitation for this study is the cross-sectional design, which limits interpretations of results to 
only inferring associations, and not the directionality of these associations. While the 
relationships among service quality, satisfaction, and purchase intentions have been causally 
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supported through other empirical studies, future studies as it applies to pharmacies should 
evaluate the temporal relationship among these constructs in longitudinal studies. Parents’ 
responses were also self-reports, which may lead to response bias in certain survey questions 
such as their children’s health status and vaccination history. While this study developed nine 
items to measure three service quality dimensions, future research should expand on this analysis 
to evaluate the construct validity of this measure of service quality in a pharmacy, and identify 
additional indicators that may increase the precision of the measure.
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TABLE 3.1 PARASURAMAN’S SERVQUAL DIMENSIONS, DEFINITIONS, AND 
COMPONENTS 
	
Dimension Definitions Included constructs 
Reliability Ability to perform the promised service dependably and accurately Reliability 
Tangibles Appearance of physical facility, equipment, personnel and communication materials Tangibles 
Responsiveness Willingness to help customers and to provide prompt service Responsiveness 
Empathy Provision of caring, individualized attention to customers 
Understanding & knowing 
the customer 
Access 






Note. Empathy comprises of two of the original service quality constructs: 
understanding/knowing the customer and access. Assurance comprises of five of the original 
service quality constructs: communication, credibility, security, competence, and courtesy.  
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TABLE 3.2 HEDVALL & PALTSCHIK’S SERVQUAL DIMENSIONS, DEFINITIONS, 
AND COMPONENTS 
	
Dimensions Definitions Included constructs 
Professionalism 
Having the customer’s best interest at heart and 







Creating an atmosphere enabling customers to feel 
that they are cared for and enabling them to feel 
free to discuss problems and ask questions 
Security 
Understanding & 
knowing the customer 
Milieu The physical premises of the pharmacy Accessibility Tangibles 
Commitment 
Making a special effort to serve the customers 
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FIGURE 3.1 THE EMOTIONAL SELF-REGULATION OF THE ATTITUDE-INTENTION RELATIONSHIP (ADAPTED 
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Note. Depicted is a simplified structural equation model. Squares represent measured variables, ovals represent latent variables 
























CHAPTER FOUR. RESEARCH AIM TWO: COMPARING PHARMACIES AND 




This chapter focuses on the Aim Two of my dissertation.  I first give a brief overview of 
the current research about preferences for pharmacies as vaccination settings. Second, I go over 
the relative advantages of pharmacies over other alternative vaccination settings, and describe a 
diffusion of innovation framework in which pharmacies may offer relative advantages over the 
traditional medical home for adolescent vaccinations. Third, I propose my hypotheses for this 
research aim. Fourth, I briefly describe the data sources and procedures for this aim. Finally, I 
end the chapter with the analytic approaches used to test my hypotheses, and conclude the 
chapter with a concise discussion of strengths and limitations. 
 
PREFERENCES FOR PHARMACIES AS VACCINATION SETTINGS 
 To date, very few studies have evaluated preferences to get adolescent vaccines, and 
specifically HPV vaccine, at pharmacies. However, the limited empirical research shows that 
parents and their adolescents prefer going to their primary care provider to get vaccines over 
other alternative vaccination settings, including pharmacies.5,6,58,60,108 In one study conducted in 
Houston, TX, only 5% of parents of adolescents ages 11 to 14 selected pharmacies as a potential 
alternative vaccination setting.58 Another smaller study conducted in Monroe County, NY also 
found that relatively few parents were willing to have their teen aged 15 to 17 vaccinated at a 
	
    
	
44 
pharmacy.108 However, that same study showed that teens were more willing to have teens 
vaccinated at a pharmacy than their parents.108 A third study conducted in Colorado also found 
parents preferred getting their adolescents vaccinated in a medical home compared to alternative 
settings.60 While the study did not explicitly ask about the acceptability of pharmacies relative to 
doctors’ offices, the comparatively lower acceptability of alternative vaccination settings may 
lead to a reasonable conclusion that pharmacies would have been deemed as less preferable, as 
well. Similarly to these three studies that focused on adolescent vaccines, two other studies found 
that parents and their adolescent sons’ comfort with HPV vaccination in alternative settings, 
including pharmacies, was lower compared to doctors’ offices.5,6 However, these studies may 
understate parents and adolescents’ interest in getting vaccinated in alternative settings because 
the study participants may not have been thinking about all the various attributes of vaccine 
delivery that could make alternative settings more attractive than primary care clinics. 
Additionally, these studies may discount the opinions of parents and adolescents who may have 
significant barriers going to a primary care provider. 
 Acceptability, willingness, or comfort with vaccination in alternative settings, including 
pharmacies, may be higher for certain groups of parents who historically have had greater 
barriers to access health care. Non-native English speaking parents were less likely to have a 
medical home or routine source of care for their adolescents, and were more likely to find 
alternative vaccination settings acceptable places for vaccinations.58 Parents living in rural areas, 
and those who found alternative settings increasingly convenient were more likely to find 
alternative settings acceptable for adolescent vaccinations.60 Additionally, parents who have not 
taken their sons to a health care provider in the past year were more likely to be comfortable with 
getting their sons HPV vaccine in alternative settings.5 Parents also cited alternative settings, 
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including pharmacies, as convenient options for HPV vaccination.5 Similar findings from 
another study showed that parents who had not taken their sons to their regular health care 
provider for routine care, and parents who perceived increased barriers to get HPV vaccine were 
more comfortable with pharmacies and schools as vaccination settings.6 Across the studies, it 
appears that medically underserved parents and their adolescents may benefit the most from 
receiving vaccination services in alternative settings like pharmacies. Thus, proper leverage of 
pharmacies as HPV vaccination outlets may serve to improve access to this and other adolescent 
vaccines, ultimately increasing uptake. 
 
RELATIVE ADVANTAGES OF PHARMACY VACCINATION SERVICES 
 Rogers’ Diffusion of Innovation Theory defines innovation as “an idea, practice, or 
object that is perceived as new by an individual.”109 An innovation can be preventive in 
nature,109 such as a vaccination service. Given its relatively new place in pharmacy practice and 
low awareness and adoption among parents of adolescents, pharmacy provision of HPV and 
other adolescent vaccinations can be viewed as an innovation within this theoretical framework. 
Rogers argues that widespread adoption of preventive innovations depends on its relative 
advantage, compatibility, complexity, trialability, and observability.109,110 While the Theory 
proposes that all the five traits of an innovation are important for widespread adoption in a social 
system, relative advantage has been found to be the single most important predictor for 
widespread adoption.109 Thus this research aim will focus on the relative advantages of pharmacy 
vaccination services and its association with willingness to get HPV vaccine from a pharmacist. 
Relative advantage of an innovation is defined as “the degree to which an innovation is 
perceived as better than the idea it supersedes.”109 An individual must merely perceive the 
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innovation as having advantages over its predecessors rather than demonstrating objective 
advantages.109 Several relative advantages of pharmacies over other alternative vaccinations 
settings, and in many instances doctors’ offices, were described in detail in Chapter 2. These 
advantages can include more convenient locations in communities,44,47,49 longer operational 
hours,44 no need for appointments,49 and little to no wait times for vaccinations.49 Anecdotes 
from community pharmacists and patients identified another possible advantage of pharmacies as 
the ability to do real-time adjudication of health services billing (i.e., knowing the cost of health 
services up front). On the other hand, parents have expressed safety and privacy concerns with 
alternative vaccination settings like pharmacies.5,6,58,60 In addition, perceptions of administrative 
and clinical staff at a pharmacy (e.g., welcoming demeanor of staff) may also play a role in 
parents’ willingness to get HPV vaccine, although this has never been empirically tested to the 
best of my knowledge. Parents may not see all the relative advantages of pharmacies or doctors’ 
offices when expressing their preferences for vaccination settings. Parents may also give more 
weight to some features (e.g., parents may value vaccination safety more over convenient 
locations or operator hours) of vaccine delivery when considering their preferred vaccination 
outlet. 
 
RESEARCH QUESTIONS AND HYPOTHESES 
 Studies have identified reasons why pharmacies may be considered acceptable 
vaccination settings. However, no studies have directly evaluated how pharmacies compare to 
doctors’ offices based on important features of vaccine delivery. Additionally, past studies have 
not explicitly tested whether the perceived advantages of pharmacies are associated with 
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willingness to get HPV vaccine from pharmacists. As a result, the research questions and 
hypotheses for my proposed Aim 2 are: 
1. When comparing a pharmacy to a doctor’s office, which vaccination setting outperforms 
the other with respect to several key aspects to vaccine delivery?  
Hypothesis 1. Compared to doctors’ offices, parents believe pharmacies are superior 
vaccination settings with respect to taking less time to get their child vaccinated, getting 
their child vaccinated without an appointment, more convenient hours to get their child 
vaccinated, and learning the cost of vaccinations before they are administered. 
Hypothesis 2. Compared to doctor’s offices, parents believe pharmacies are inferior 
vaccination settings with respect to vaccination safety, privacy during vaccination, and 
having more welcoming staff. 
2. How are perceived relative advantages of pharmacy and doctor’s offices with respect to 
vaccination services associated with parents’ willingness to get HPV vaccine from a 
pharmacist? 
Hypothesis 3. Parents who indicate the most important feature of vaccination is taking 
less time to get their children vaccinated, getting their children vaccinated without an 
appointment, more convenient hours to get their children vaccinated, or learning the cost 
of vaccinations before they are administered will be more willing to get HPV vaccine 
from a pharmacist compared to parents who indicate the most important feature of 
vaccination is vaccination safety, privacy during vaccination, or having more welcoming 
staff. 
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Hypothesis 4. Parents who identify more advantages for getting their children vaccinated 
at pharmacies will have higher willingness to get their children HPV vaccine from a 
pharmacist. 
Research also shows that certain beliefs, attitudes, and sociodemographic characteristics 
of parents and adolescents are associated with greater acceptability and comfort with alternative 
settings, but these correlates are not consistent across studies. Additionally, the applicability of 
these correlates of support to pharmacy provision of HPV and other adolescent vaccines are 
limited by previous studies’ inclusion of other alternative vaccination settings such as schools 
and health departments, which can mask true support of pharmacies as vaccination settings. As 
an exploratory component to the study hypotheses, I will also characterize how 
sociodemographic characteristics of parents and their adolescents are associated with perceived 
relative advantages of pharmacies or doctors’ offices. 
 
SIGNIFICANCE AND IMPLICATIONS OF THE STUDY 
 Successful implementation of adolescent vaccination programs in pharmacies depends on 
understanding the features of vaccine delivery that are important to parents. Using the concept of 
relative advantage from Diffusion of Innovation theory offers a sound, empirical basis to explore 
attitudes of different vaccine delivery features. Leveraging the features of vaccine delivery that 
are important to parents getting their children vaccinated would be a particularly effective 
business strategy for pharmacies looking to expand their vaccination platform and clinical 
services. Equally as important, identifying vaccine delivery features that parents believe to be 
inferior in pharmacies compared to doctors’ offices also provides a starting point for quality 
	
    
	
49 
improvement on current community pharmacy practice models to meet patient expectations of 
quality adolescent vaccine delivery. 
 
OVERVIEW OF DATA SOURCE AND PROCEDURES 
 Data source. The data for this research aim come from the AVIP study. I describe the 
study in Chapter 3, and all variables for this study are located in Appendix 2. 
 Vaccination site comparison items. Parents responded to eight items about the relative 
advantages of pharmacies and doctors’ offices. They were first prompted to “imagine [CHILD’S 
NAME] needed a vaccine such as tetanus booster, meningitis vaccine, or HPV vaccine. Also 
imagine these vaccines are available at pharmacies and doctor’s offices.” Then parents answered 
seven questions about whether a pharmacy or doctor’s office would be better at a particular 
characteristic of vaccine delivery. Parents could respond by selecting “pharmacy,” “doctor’s 
office,” or “they’re the same.” Finally, parents were asked “which of these is most important 
when choosing between a pharmacy and a doctor’s office as a place to get [CHILD’S NAME] 
vaccinated?” Parents responded by selecting what they believed to be the most important 
characteristic of vaccine delivery for their children. 
HPV vaccination willingness and covariates. The outcome of interest for this study is 
willingness to get HPV vaccine from a pharmacist. This variable and other potential covariates 
were previously described in Chapter Three and are located in Appendix II. 
 Missing data. Missing responses for any given survey item for this research aim is no 
more than 1.9%. I will use multiple imputations to generate datasets with imputed values using 
Stata 13.1 (College Station, TX). 
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AIM TWO ANALYTIC APPROACH 
I will use Stata version 13.1 for data cleaning and variable recoding, descriptive statistics, 
and other basic analyses and regression analyses. All statistical tests will use two-tailed tests with 
a critical alpha of 0.05.  
Beliefs about relative advantages. I will begin my analysis by examining the proportion 
of parents who believe pharmacies are superior (or inferior) to doctors’ offices for seven features 
of vaccine delivery (hypotheses 2.1 and 2.2). First, I will generate new site comparison variables 
based on the original items (Appendix 2; IV1-IV7) where I drop the parents who indicated that 
pharmacies and doctors’ offices are the same. I will then code the new site comparison variables 
so that “doctor’s office” is the referent (coded “0”) and “pharmacy” is the non-referent category 
(coded “1”). I will then conduct tests on the equality of proportions using large-sample statistics, 
which is similar to Student’s t-test but for dichotomous outcomes. The null hypotheses for this 
test will be that the proportion of parents who indicate pharmacies are better will be the same as 
the proportion of parents who indicate doctors’ offices are better (i.e., the proportion between the 
two groups of parents equals .5 for the null hypotheses). Based on hypothesis 1 and hypothesis 
2, I predict that: 
§ Prediction 1: A higher proportion of parents will believe pharmacies are superior to 
doctors’ offices with respect to (1) taking less time to get their child vaccinated, (2) 
getting their child vaccinated without an appointment, (3) more convenient hours to get 
their child vaccinated, and (4) learning the cost of vaccinations before they are 
administered. 
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§ Prediction 2: A lower proportion of parents will believe pharmacies are superior to 
doctors’ offices with respect to (1) vaccination safety, (2) privacy during vaccination, and 
(3) having more welcoming staff. 
 Differences in HPV vaccination willingness by vaccine delivery feature. For the second 
set of analyses, I will examine how willingness to get HPV vaccine from a pharmacist varies by 
the importance placed on the seven vaccine delivery feature (hypothesis 3). First I will use 
descriptive statistics to characterize the proportion of parents who indicate which feature of 
vaccine delivery was most important to them (IV8 in Appendix 2). Next, I will conduct an 
independent sample (between subjects) Student’s t-test comparing the mean willingness for 
responses that I predict will be higher for pharmacies compared to doctors’ offices. Then I will 
conduct an analysis of variance (ANOVA) to evaluate if there are differences in willingness to 
get HPV vaccine among groups of parents who indicated the most important feature of vaccine 
delivery were taking less time to get their children vaccinated, getting their children vaccinated 
without an appointment, more convenient hours to get their children vaccinated, or learning the 
cost of vaccinations before they are administered. Similarly, I will also conduct a second 
ANOVA to evaluate if there are differences in willingness to get HPV vaccine among groups of 
parents who indicated the most important feature of vaccine delivery were vaccination safety, 
privacy during vaccination, or having more welcoming staff. Based on hypothesis 3, I predict 
that:  
§ Prediction 3: Mean willingness will be higher for parents who responded 2, 3, 4, and 5 to 
the importance item compared to parents who responded 1, 6, and 7 (!"	 = !$ = !% = !& > 
!'	 = !( = !); p<.05). 
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 Correlates of HPV vaccination willingness. For the third set of analyses, I will evaluate 
how parents’ beliefs about the relative advantages of pharmacies and doctors’ offices as 
vaccination settings are associated with willingness to get their children HPV vaccine from 
pharmacists (hypothesis 4). I will begin by creating a contrast code for the site comparison items 
(IV1 – IV7) so that parents who indicate a doctor’s office is better are coded as “-1,” parents who 
indicate that a pharmacy and doctor’s office are the same are coded as “0,” and parents who 
indicate a pharmacy is better coded as “1.” I will then generate a composite variable summing 
the contrast coded site comparison items, where composite scores will range from “-7” to “7,” 
and then rescale the composite item so that scores are bounded between “-1” and “1.” I will then 
test the bivariate association between parents’ willingness to get HPV vaccine with the 
composite variable, as well as several covariates specified in the data source and procedures 
section of Chapter 3. All statistically significant correlates will then be combined in a 
multivariable linear regression model. All regression analyses will used Huber-White robust 
standard errors to account for any heteroskedasticity,111 and will report standardized regression 
coefficients (βs). Based on hypothesis 4, I predict that:  
§ Prediction 4: Adjusting for statistically significant covariates, higher composite scores 
will correlate with higher willingness (β-coefficient on composite score > 0; p<.05). 
As an exploratory analysis, I will also evaluate how sociodemographic characteristics of parents 
and adolescents correlate to the relative advantages composite indicator. 
 
STRENGTH AND LIMITATIONS 
 To the best of my knowledge, this will be the first study to empirically evaluate the 
differences between pharmacies and doctors’ offices on various features of adolescent vaccine 
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delivery, and how these features are associated with parents’ willingness to get their children 
HPV vaccine from pharmacists. Data from this study come from a national sample of U.S. 
parents of adolescents with a good response rate for online surveys. Additionally, survey items 
were developed based on previous empirical research on the preferences for alternative 
vaccination settings for adolescents, and based on feedback from pharmacy practice experts and 
cognitive interviews of parents of adolescents. A notable limitation for this study is the cross-
sectional design, which limits interpretations of results to only inferring associations, and not the 
directionality of these associations. Parents’ responses were also self-reported, which may lead to 
response bias in certain survey questions like their children’s health status and vaccination 
history, or lead to an overestimation of their willingness to get HPV vaccine from pharmacists. 
While the study focuses on several provider-level characteristics of vaccine delivery, there may 
be other features of vaccine delivery that are important predictors to parents’ willingness to get 
HPV vaccine from pharmacists. 
	




CHAPTER FIVE. RESEARCH AIM THREE: PHARMACISTS’ IMPACT ON THE 
AVAILABILITY OF VACCINE PROVIDERS 
 
OVERVIEW 
 This chapter focuses on Aim Three of my dissertation.  I first give a brief overview of 
several studies that have evaluated geographic disparities in HPV vaccination. Second, I provide 
a rationale for the link between health care access to vaccination services and geographic 
disparities in HPV vaccination. Third, I propose the potential role that pharmacists have in 
addressing geographic disparities in HPV vaccination. Fourth, I propose my hypotheses for this 
research aim. Fifth, I describe the data sources and procedures I will use for my analysis. Finally, 
I end the chapter with the analytic approaches used to test my hypotheses, and conclude the 
chapter with a concise discussion of strengths and limitations. 
 
GEOGRAPHIC DISTRIBUTION OF HPV VACCINATION 
 In recent years, there has been great interest in characterizing how vaccination coverage 
varies geographically, particularly for HPV vaccination. While there are studies about 
geographic variation of HPV vaccination in adults,112-114 for the purpose of this dissertation aim, 
I will focus on studies whose target populations are pre-adolescents and adolescents.62,63,115-119 
This is because contributing factors for HPV vaccination in adults may differ from those 
influencing vaccination for adolescents. The studies can be grouped into national-, state-, and 
local-level geographic analyses. 
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Several studies using national surveys have shown that HPV vaccination coverage varies 
among states, and have identified potential explanations for these geographic disparities. NIS-
Teen data consistently show that vaccination coverage varies substantially among states. In the 
most recent data from 2014, HPV vaccine series completion ranged from 20% (Tennessee) to 
57% (Washington D.C.) for girls, and 9% (Alabama) to 43% (Rhode Island) for boys.1 A 2016 
study using 2011 and 2012 NIS-Teen data evaluated how individual and neighborhood 
characteristics affected HPV vaccine initiation among 13-17 year old girls. Henry and colleagues 
found that girls living in low-income communities had higher vaccination rates.63 Studies have 
also used Behavioral Risk Factor Surveillance System’s (BRFSS) survey data to estimate 
geographic disparities in HPV vaccination. One study using 2008 BRFSS data found significant 
geographic disparities in parent-reported HPV vaccine initiation in Delaware, New York, 
Oklahoma, Pennsylvania, Texas, and West Virginia, with coverage ranging from 21% (Texas) to 
50% (New York) for girls ages 13 to 17.115 A second study using 2010 BRFSS also found 
vaccination coverage to differ from state to state for boys and girls ages 9 to 17.120 Interestingly, 
the NIS-Teen data found community-level poverty was positively associated with HPV 
vaccination coverage,63 while poverty measured at larger spatial units (e.g., state) in BRFSS was 
negatively associated with HPV vaccination coverage.115 These conflicting results highlight that 
statistical inferences about correlates of HPV vaccination may be misleading as units of analysis 
are aggregated, although they may also reflect important differences in the data sources (e.g., 
provider-verified vaccination in NIS-Teen as compared to parent self-report in BRFSS). 
Studies have also looked at geographic disparities in vaccination coverage within states. 
One study using 2008 BRFSS data from Texas found that county initiation rates ranged from 7% 
to 29% for girls ages 11 to 17.116  Similar to the previously described national studies, this 2008 
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study found that county-level poverty was associated with higher vaccination coverage, while the 
larger public health region was associated with lower vaccination coverage, demonstrating a 
similar discrepancy in association as units of analyses are aggregated. Two studies in North 
Carolina also found geographic variation in vaccination coverage. The first NC study, aimed at 
reevaluating strategies in cervical cancer prevention, found that HPV vaccine initiation rates for 
girls varied by county, ranging from 15% to 62%.119 The second NC study found areas in North 
Carolina with especially low coverage of publicly funded HPV vaccinations for uninsured or 
publicly insured boys and girls.62 Trogdon and Ahn note that contributing factors to higher 
vaccination coverage were being racial and ethnic minorities, religious institutions per capita in 
an area, and outpatient visits per capita in a local area.62 Factors that appear to be associated with 
lower vaccination coverage included area-level poverty, proportion of population with less than 
high school education, and health professional shortage areas.62 
Finally, studies have also looked at local-area geographic disparities in HPV vaccination. 
Two studies in Los Angeles evaluated access to HPV vaccination services at safety-net clinics in 
high-risk communities. The first study found that most people who live in high-risk communities 
for HPV-associated cancers and chlamydia lived within three miles of HPV vaccination services 
through safety-net clinics, with the exception of two high-risk neighborhoods “located outside of 
the primary urban core.”117 The researchers noted that low-income residents living in less 
impoverished neighborhoods face greater barriers to accessing safety-net clinics.117 Finally, other 
health care organizational factors such as limited clinic hours may be contributing to the overall 
low uptake of HPV vaccine.117 A follow-up study found that proximity to a safety-net clinic that 
provided HPV vaccination services did vary for racial and ethnic minorities, with Asian 
minorities (Chinese and Korean) living the furthest away.118 However, 80% of low-income girls 
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lived within three miles of a safety-net clinic, leading the researchers to conclude that increasing 
outreach of existing services is more of a priority than reducing geographic barriers in accessing 
vaccination services in Los Angeles.118 This study’s sample was modest (n = 479) and 
homogenous, which may account for the lack of associations between predictor variables and 
vaccination coverage and limits generalizability to the rest of Los Angeles residents. 
 In summary, these studies show that geographic disparities in HPV vaccination exist both 
among and within states. However, differences among these studies make it unclear why these 
geographic disparities may exist. Across the studies, racial and ethnic minorities, particularly 
those who identify as Hispanic, have higher vaccination coverage. However, there is 
disagreement of how socioeconomics factors such as income, education, and area-level poverty 
are associated with vaccination coverage. As mentioned earlier, one reason for the diverging 
results is how the unit of analysis was derived and aggregated to get population level 
estimates.62,115,116 A second reason is that some of these studies focused on populations who are 
medically underserved or disenfranchised,62,117,118 which can cause problems for inferring 
generalizability. 
 
HEALTH CARE ACCESS AND VACCINATION  
Characteristics of health care systems and the communities people live in can influence 
their access to vaccination services and, in part, influence their use of vaccination services. 
Researchers have long noted that where people live matters and can influence their ability to 
obtain health care and the probability of obtaining quality health care.121 Andersen’s Behavioral 
Model of Health Care Utilization is the most widely used model to conceptualize individual and 
contextual factors that promote and discourage health care use.122,123 Andersen describes a set of 
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factors as “enabling” health care utilization.122 Many of these enabling factors are at the 
individual level, such as income and health insurance status.122 Other enabling factors are at the 
community level, such as the number of health care facilities and personnel in a neighborhood.122  
The spatial patterns of HPV vaccination and screening, and their association with cancer 
incidence117,124 and mortality124 suggest that spatial targeting of public health interventions may 
reduce geographic disparities. As an example, high cervical cancer burden in Appalachia are 
associated with low HPV vaccination coverage.125 Reiter and colleagues suggest that lower 
vaccination coverage may be due to greater barriers in accessing primary care.125 Three of the 
previously described studies explicitly looked at health care access as a contributing factor for 
HPV vaccination.62,117,118 While the two studies in Los Angeles did not find a correlation 
between location of safety-net clinics and vaccination coverage, the researchers noted it is 
possible that other characteristics of the health care system (e.g., clinic operating hours) could 
influence access and use.117 Additionally, the LA study’s sample was modestly sized and 
homogenous, likely making it not representative of the rest of LA residents. In contrast, the 
North Carolina study suggested that areas with health professional shortages are associated with 
lower vaccination coverage.62  
 
ACCESS TO AND USE OF PHARMACY-LOCATED VACCINATIONS 
 Typically, in HPV vaccination research, most measures of health care use examine access 
to and interactions with primary care providers such as pediatricians and family medicine 
physicians (hence forth referred to as primary care physicians). This makes sense as the large 
majority of adolescent vaccinations are given in practices with these two primary care 
specialties.33 However, lower health care utilization patterns among adolescents in the United 
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States30-32 suggests that additional modes of accessing vaccination may improve vaccination 
coverage. Moreover, the unequal distribution of primary care physicians in communities also 
warrants the investigation of the accessibility of alternative vaccination settings.  
As discussed in Chapter Two, pharmacies are an ideal alternative to the traditional 
medical home for vaccinations. NACDS reports that 93% of U.S. residents live within five miles 
of a community pharmacy.38 Research also suggests pharmacies have more convenient hours and 
ease of access within neighborhoods compared to primary care clinics.44,46-48 Table 5.1 shows 
unpublished data from the AVIP study on average time (in minutes) it takes a parent to get to a 
pharmacy and his or her child’s doctor’s office. The paired t-tests show that parents were closer 
to pharmacies where they usually go to get their children’s prescriptions as compared to their 
children’s doctors’ office in both urban and rural areas. Taken together with the data from 
NACDS, one may infer that pharmacists are more geographically dispersed (e.g., they may not 
cluster as much in location) compared to primary care physicians. The lower amounts of 
clustering may be due to pharmacy businesses wanting to avoid competition with each other in a 
given area.  The data may also suggest that pharmacists are located closer to residential areas 
compared to primary care physicians. 
 Research presented in Chapter Two also suggests that very few parents are going to 
pharmacies to get HPV vaccine for their children, but unpublished findings from the AVIP 
survey show that parents may be using pharmacies to get other vaccines for their children (Table 
5.2). About eight percent of parents in the AVIP sample (n/N = 119/1,504) have used a pharmacy 
to get their child vaccinated. Among these parents, 84% went to a pharmacy to get their child 
influenza vaccine (n = 100), nine percent to get adolescent vaccines (n = 11), and eight percent to 
get other non-adolescent vaccines (n = 10). The preference for parents to get influenza vaccine 
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over other vaccines for their children at a pharmacy may be driven in part by the yearly 
promotion of seasonal influenza vaccinations. Additionally, pharmacists have been providing 
influenza vaccinations for a much longer period of time than other vaccines, which may lead to 
greater awareness among parents and capacity for this service. Thus, meaningful use of 
pharmacies for vaccinating children may be directed towards vaccines outside of the adolescent 
platform. However, these data suggest that some parents do seek vaccinations in pharmacies for 
their children, and offers a possible setting to further establish the use of adolescent vaccines like 
HPV vaccine in pharmacies. 
 
RESEARCH QUESTION AND HYPOTHESES 
Studies have looked at issues of access to and use of HPV vaccination services. However, to 
the best of my knowledge, no studies have explicitly examined access to pharmacist-provided 
vaccinations compared to access to primary care physician-provided HPV vaccinations. Thus, 
the purpose of this dissertation aim is to understand how pharmacists can improve access to HPV 
vaccination services in areas that may be considered primary care shortage areas and have low 
vaccine coverage. The research questions and hypotheses for Aim 3 are:  
1. Are primary care physicians more geographically clustered than pharmacists? 
Hypothesis 1. Primary care physicians are more spatially clustered than pharmacists. 
If physicians are more geographically clustered than pharmacists, this will provide evidence 
that parents and their children may be geographically closer to pharmacists, and thus have easier 
access to pharmacists than access to primary care physicians. 
2. Will including pharmacists as primary care providers increase the number of areas with 
adequate health care provider coverage? 
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Hypothesis 2. The number of areas with adequate health care provider coverage increases 
if pharmacists are included with primary care physicians as adolescent vaccine providers. 
In addition to being geographically more dispersed, there are also some findings that 
support pharmacists are more readily located in areas that can be considered medically 
underserved.10,47 If pharmacists can fill in gaps in primary care shortages, then this may present 
an opportunity for parents and adolescents who face greater barriers to accessing primary care 
physicians to find some types of preventive care like adolescent vaccinations in pharmacies. 
 
SIGNIFICANCE AND IMPLICATIONS OF THE STUDY 
Targeted strategies to improve local HPV vaccination coverage can begin by identifying 
areas that are potential “health care deserts” for primary care physicians, and complement 
vaccination efforts in those areas with alternative vaccine providers like pharmacists. If 
pharmacists are located in communities at a higher frequency compared to primary care 
physicians, particularly in areas of low vaccination coverage, public health researchers are 
warranted in promoting interventions that use pharmacies as additional vaccination outlets. 
Additionally, geographic studies that account for additional health care resources outside of 
traditional medical homes can help identify ways to improve or optimize existing health care 
systems in communities, especially in situations where adolescents and parents face substantial 
barriers to accessing primary care providers. 
 
OVERVIEW OF DATA SOURCES AND PROCEDURES 
 Protocol for choosing study state. I focus on one state for the purpose of this research aim 
since pharmacy practice laws governing a pharmacist’s authority to vaccinate are state specific. I 
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selected Texas based on inclusion and exclusion criteria I applied to the 48 contiguous states in 
the U.S. The two main inclusion criteria were: 
1. Allowing pharmacists to vaccinate adolescents as young as 11 with HPV vaccine, and  
2. Requiring reporting vaccine doses to the state immunization information system (IIS) or 
having high participation rates in the IIS from the study population. 
Exclusion criteria that I considered for state selection were: 
3. Higher than national average HPV vaccination rates for boys and girls, and  
4. Small pharmacy work force. 
Based on these criteria, potential states for this study were Mississippi, New Mexico, Texas, and 
Washington. After contacting each state’s immunization branch, Texas and New Mexico agreed 
to provide data for this study. I ultimately selected Texas as it has a larger population that is 
geographically dispersed, and has a large pharmacy work force. 
 Vaccination data. Vaccination data will be collected from ImmTrac, the Texas 
Immunization Branch’s IIS. While all vaccine providers are required to report any vaccine dose 
to ImmTrac, individual participation in ImmTrac is voluntary. However, ImmTrac has around a 
92% participation rate from all individual less than 18 years of age in Texas. Thus, estimated 
coverage for adolescent vaccines will be fairly accurate. ImmTrac will provide vaccination 
coverage for HPV vaccine series initiation (³1 dose), HPV vaccine series completion (³3 doses), 
and HPV vaccine series follow-through (percentage who completed HPV vaccine series among 
those who initiated). ImmTrac will also report vaccination coverage for meningococcal, Tdap, 
and influenza vaccines. Since ImmTrac cannot report on individual counts for vaccinations, all 
vaccination rates will be reported as percentage of pre-adolescents or adolescents vaccinated in a 
given zip code. ImmTrac will not report vaccine coverage for zip codes that have 50 or fewer 
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pre-adolescents and adolescents. Vaccination coverage that will be reported will be stratified by 
the following age cohorts: 9-10 year olds, 11-12 year olds, 13-17 year olds, and 11-17 year olds. 
Additionally, ImmTrac will provide coverage estimates for the 2010 to 2015 calendar years. 
 Pharmacists workforce data. Pharmacist workforce data will come from the Texas Board 
of Pharmacy (available at: http://www.pharmacy.texas.gov/dbsearch/tables.asp). These data are 
publically available and updated regularly. Information reported includes the pharmacist’s name, 
license number, public address (place of employment), employment type (e.g., community, 
hospital), and license status (e.g., active, inactive, expired). For my analysis, I will only include 
pharmacists with active licenses who work in community pharmacies. 
Primary care physician workforce data. Physician workforce data will come from the 
Texas Medical Board (available at: http://store.tmb.state.tx.us/). Similar to the pharmacist data, 
physician data are publically available and include physician name, license type, activity status, 
practice address, and practice specialty. For my analysis, I will only include physicians with 
active licenses who practice in pediatrics and family medicine in outpatient clinics. 
 Census data. Demographic variables for race and ethnicity and total population will come 
from the 2010 Census.126 I will use the Census Bureau’s American Community Survey, 2010-
2014 estimates,127 to estimate additional sociodemographic characteristics such as percentage of 
children ages 9 to 17  with different types of insurance and the percentage of population with 
various educational attainment (e.g., less than high school, some college). I will also collect 
geographic boundaries of Texas using the 2015 TIGER shape file (available at: 
https://www.census.gov/geo/maps-data/data/tiger-line.html). 
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 Additional covariates. Additional county characteristics such as persistent poverty and 
outpatient visits per capita will come from the Area Health Resource File (AHRF; available at: 
http://ahrf.hrsa.gov/download.htm).  
Data preparation. Practice addresses will be available from pharmacist and primary care 
physician workforce datasets. Practice addresses will be geocoded and merged to shape files by 
joining the geocoded points to a geographic spatial unit such as census tracts or Zip Code 
Tabulation Area (ZCTAs). The first attempt for geocoding will be to join the workforce data 
with census tracts, as these are both geographically and economically meaningful units. If 
joining the geocoded workforce data to census tracts is not feasible, then I will use ZCTAs. Since 
zip codes are not geographic units used by the Census Bureau, I will cross-walk zip codes to Zip 
Code Tabulation Areas (ZCTAs) using a procedure developed by the Robert Graham Center.128 
ZCTAs were created by the U.S. Census Bureau to provide an aggregated unit of analysis that 
approximates the shape of zip codes. ZCTAs will provide satisfactory variation in vaccination 
coverage while also having sufficient data to approximate area-level characteristics.62 Texas has 
2,600 zip codes that aggregate to 1,936 ZCTAs.128 Census-tract and county-level characteristics 
will be converted to ZCTAs using weighted averages.62 I will use Stata 13.1 to merge datasets, 
clean data (e.g., ZCTA conversions), and conduct multiple imputation procedures for missing 
cases where vaccination coverages in zip codes were unavailable.  
Geographic information system (GIS) processing. I will use ArcGIS (Redlands, CA) 
software (or similarly the open source software QGIS) to conduct geoprocessing functions and 
manage geospatial data. After cleaning and merging datasets in Stata 13.1, I will import the 
cleaned dataset into ArcGIS and examine maps for merge errors. I will then use the GIS software 
to map the location of pharmacists and primary care physicians based on their coordinates that 
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are geocoded from their publicly available addresses. By having each pharmacist and primary 
care physician geocoded, I can derive area estimates of the number of pharmacists and primary 
care physicians by geographic area, Euclidian or Manhattan distances from census tract 
centroids, or a ratio of providers to patient population for each census tract. 
 
AIM THREE ANALYTIC APPROACH 
I will use ArcGIS or Stata 13.1 for descriptive statistics, geospatial statistical tests, and 
other basic analyses. All statistical tests will use two-tailed tests with a critical alpha of 0.05.  
  Geographic dispersion of pharmacists and physicians. I will begin my analysis by 
evaluating the spatial autocorrelation of pharmacists and physicians based on the reported 
practice addresses provided by the Texas Board of Pharmacy and Medical Board (hypothesis 1). 
Using ArcGIS, I will calculate a global Moran’s I for the spatial distribution of pharmacists and 
primary care physicians to assess the extent of spatial autocorrelation.129 The formula for 
Moran’s I is: 
* = 	 , -./0/1'0.1'




Where n is the number of ZCTAs, yi and yj are the number of pharmacists or primary care 
physicians in locations i and j, -./ is the neighbor spatial weight,	(3. − 3)(3/ − 3)	is the 
covariance term, and (3. − 3)"0.1'  is the normalization term to scale I to the overall variance in 
the dataset. To calculate the spatial weights, I will use a first order queen criterion to identify 
adjacent observations to be included as “neighbors” (e.g., neighboring census tracts), and use 
row standardization so that different census tracts are comparable to one another. Moran’s I is 
analogous to Pearson’s correlation coefficient; it provides a summary over the entire study area 
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of the level of spatial similarity observed among neighboring observations.130 Moran’s I ranges 
from -1 to 1, and variables that have high spatial clustering will have a Moran’s I that approaches 
|1| (with some exceptions going out of range). 
 Since values of Moran’s I are scale dependent (i.e., the values I takes depends on the 
scale of the geographic unit of analysis), there are instances where global Moran’s I gives an 
incorrect measurement of autocorrelation for a study area. Thus, I will also consider calculating 
local indicators of spatial association (LISAs), which provide a local measure of similarity 
between each neighbor’s associated value and those of nearby neighbors.131 The most commonly 
used LISAs is local Moran’s I, which is a transformation of the global Moran’s I for any given 
geographic region in a study area.131 In addition to calculating Moran’s I, I will generate 
choropleth maps to visualize the spatial autocorrelation among pharmacists and primary care 
physicians. Based on hypothesis 1, I predict that:  
§ Prediction 1: Primary care physicians will be positively spatially autocorrelated (IMD>0; 
p<.05). 
§ Prediction 2: Pharmacists will be positively spatially autocorrelated (IRx>0; p<.05). 
§ Prediction 3: The spatial clustering of primary care physicians will be more than the 
spatial clustering of pharmacists (IMD>IRx; p<.05). 
Pharmacists’ role in primary care health professional shortage areas. For the second 
analysis, I will descriptively evaluate how the number of primary care health professional 
shortage areas (HPSA) in Texas will change if pharmacists are included as primary care 
providers (hypothesis 2). The Health Resources and Services Administration define a geographic 
area as a primary care HPSA if it:132 
§ Is a rational area for the delivery of primary medical care services. 
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§ Meets one of the following conditions: 
o Have a population to full-time-equivalent primary care physician ratio of at least 
3,500:1. 
o Have a population to full-time equivalent primary care physician ratio of less than 
3,500:1 but greater than 3,000:1 and have unusually high needs for primary care 
services or insufficient capacity of existing primary care providers. 
§ Demonstrates that primary medical professionals in contiguous areas are overused, 
excessively distant, or inaccessible to the population under consideration (detailed 
definition available at: https://ruralhealth.und.edu/pdf/hpsa.pdf). 
Within the definition, primary medical professionals only count as physicians. Additionally, 
population is defined as the total population living in a geographic area. Since I will not have 
data to reliably demonstrate if primary medical professionals are overused, excessively distant, 
or inaccessible in a given area, I will focus my definition of primary care shortages as the ratio of 
population to the number of primary medical professionals. In order to evaluate the number of 
ZCTAs that can be designated as an HPSA, I will first calculate the ratio of total population to 
primary care physicians. Any census tracts that have a population to primary care provider 
(physicians only) ratio of at least 3,500:1 will be designated as a shortage area. I will then 
redefine HPSAs to also include community pharmacists, and recalculate the ratio of total 
population to primary care physicians and pharmacists. Under the new HSPA definition, any 
census tracts that have a population to primary care provider (physicians and pharmacists) ratio 
of at least 3,500:1 will be designated as a shortage area. I will use a proportion test to evaluate if 
the number of census tracts that are shortage areas significantly differ based on the two 
definitions of HSPAs. Based on hypothesis 2, I predict that: 
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§ Predication 4: There will be fewer census tracts with shortage areas if I designate HPSA 
to also include pharmacists. 
In addition to the analysis plan for hypothesis 2, I will also consider an alternative approach by 
evaluating whether the ratio of primary care providers to patient population will rise more in 
areas with primary care shortages compared to areas with no shortages if pharmacists are 
included as primary care providers. 
 
STRENGTHS AND LIMITATIONS 
 To the best of my knowledge, this will be the first study to analyze the distribution of 
pharmacists and primary care physicians and how this pattern is associated with HPV 
vaccination coverage in Texas. This study benefits from high adolescent participation in 
ImmTrac, which will help generate fairly accurate vaccination coverage estimates. This study 
also benefits from having a census of the pharmacist and primary care physician workforce that 
will allow for accurate analyses of the geographic distribution for these two types of health care 
providers. Additionally, this study will also be able to provide information on how vaccination 
trends varied over time within the state. An important limitation is that if I use ZCTAs rather 
than census tracts, the interpretation of results can lead to representational error in spatial 
analyses because ZCTAs were not created as geographic markers.133 Additionally, no inferences 
can be made about individual-level characteristics since vaccination data provided by ImmTrac 
will be aggregated at the level of zip codes. Finally, while this study is primarily ecological, 
there are many contributing factors at the state, county, and local level that may affect 
vaccination coverage that cannot be accounted for, such as the availability of publically funded 
vaccination programs (e.g., Vaccines for Children), the change in the number of providers in an 
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area over time, and the movement of families from one area to another both within and out of the 
state.
	
    
	
70 
TABLE 5.1 PARENT’S REPORTED TIME TO HEALTH CARE SETTING 
	
  
Pharmacy   
Mean minutes (CI95%) 
Doctor’s office  
Mean minutes (CI95%) t 
Rural (n = 233) 14.8 (13.0 - 16.7) 18.5 (16.3 - 20.3) 3.91 (p<.001) 
Urban (n = 1240) 11.1 (10.5 - 11.7) 17.5 (16.8 - 18.2) 16.78 (p<.001) 
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TABLE 5.2 TYPE OF VACCINES PARENTS GOT FOR THEIR CHILDREN AT 
PHARMACIES 
	
   n (%) 
Vaccine type   
Flu 100 (84) 
Other vaccines 10  (9) 
Tdap 6  (5) 
HPV 4  (3) 
Meningococcal 1  (<1) 
Note. Parents were able to choose multiple vaccines for their children. 
 
	




CHAPTER SIX. STUDY ONE: THE ROLE OF PHARMACY TYPE IN PARENTS’ 
WILLINGNESS TO GET HPV VACCINE FROM PHARMACISTS 
 
INTRODUCTION 
The President’s Cancer Panel and the National Vaccine Advisory Committee recommended 
expanding HPV vaccine provision in pharmacies as one strategy to improve access to and 
opportunities for HPV vaccinations,3,4 whose rates have lagged considerably behind those of 
tetanus, diphtheria, and acellular pertussis (Tdap) and meningococcal vaccinations.134 Since 
1994, pharmacists have played an increasingly large role in immunization efforts,35 and may be 
well positioned to improve HPV vaccine uptake. For instance, 20% of U.S. adults received their 
influenza vaccine from chain or supermarket pharmacies in 2011-2012.43 Pharmacies have 
tremendous potential reach within communities; consumers make an estimated 250 million visits 
to pharmacies each week,135 and about 93% of U.S. residents live within five miles of a 
community pharmacy.38 Pharmacies also have longer operating hours and are easier to access 
within communities compared to traditional medical settings when considering vaccination 
services.44,46-48 
A recent study found that almost one-third of parents were willing to get their children HPV 
vaccine from pharmacies.136 However, the study did not examine how parents’ willingness to get 
their children vaccinated from pharmacists varies by the types of pharmacies they typically 
frequent. This is important to understand because customers may hesitate to engage in pharmacy-
located adolescent vaccination due to varying degrees of perceived quality in the health care 
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services provided at different pharmacies. For example, patients surveyed by Consumer Reports 
highly rated independent-owned pharmacies or pharmacies located in health systems like Kaiser 
Permanente, while less favorably rating chain pharmacies like Walgreens and Walmart.137 In 
turn, we hypothesized that parents who go to independent pharmacies or pharmacies located in a 
clinic or hospital have higher willingness to get their children HPV vaccine from a pharmacist 
than parents who go to chain pharmacies (Hypothesis 1).  
Understanding how customers’ perceptions of quality develop may help pharmacies find 
tangible ways to improve their health care delivery, ultimately increasing customer engagement 
with their products and services.66 Marketing research has demonstrated that consumer 
perceptions of service quality and their feelings of satisfaction are strong predictors of consumer 
engagement with services.7,66,68-71 The conceptualization that service quality perceptions for a 
particular business will elicits an emotion response of satisfaction, which in turn leads to 
engagement with an established or new service or product in that business is grounded in 
Lazarus’ emotion and adaptation8 and Bagozzi’s self-regulation of attitudes and intentions 
frameworks.65 By extension, it may be reasonable to conclude that consumers’ service quality 
perceptions may vary by the types of pharmacy they go to, which in turn results in varying levels 
of satisfaction and willingness to engage in new services like adolescent vaccination. As such, 
we hypothesized that the association of pharmacy type on parents’ willingness to get their child 
HPV vaccine from a pharmacist will be mediated by perceptions of service quality and overall 
satisfaction with health care services at the pharmacy (Hypothesis 2). 
To the best of our knowledge, no study has examined how different kinds of pharmacies 
parents go to for their children’s medications may affect their perceptions of service quality, 
feelings of satisfaction, and willingness to get HPV vaccination. As such, the purpose of this 
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study was to examine how the type of pharmacy parents report using is associated with their 
willingness to get HPV vaccine for their children from pharmacists.  
 
METHODS 
Data source and procedures 
Study participants. The Adolescent Vaccinations in Pharmacies (AVIP) Study was an 
online, cross-sectional survey of U.S. parents of adolescents conducted from November 2014 to 
January 2015. Study participants were members of an existing, national panel of non-
institutionalized adults maintained by a survey company.83 The national panel was created 
through probability-based sampling of U.S. households using a combination of random-digit 
dialing and address-based sampling frames. Eligible respondents were parents of at least one 
child ages 11 to 17 who lived with them at least half of the time. Parents answered survey items 
about their children who they identified at the beginning of the survey.  
Analytic sample. The survey company randomly selected 2,845 parents from a panel 
comprised of members from all 50 states and the District of Columbia. Approximately 14% 
(n=391) of invited panelists were not eligible to complete the survey. Of the 2,454 eligible 
parents, 1,518 completed some portion of the survey. After we excluded 14 panelists who did not 
complete at least two-thirds of the survey, our final analytic sample contained 1,504 parents 
whose sociodemographic characteristics are summarized in Table 6.1. The response rate was 
61% (1,504/2,454) based on American Association for Public Research Response Rate Five.84,85 
Measures 
Survey item development. We developed survey items based on previous research among 
parents, adolescents, and health care providers,86-90 or adapted items from other sources.7,91,92 We 
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cognitively tested the AVIP survey with 18 parents of adolescents ages 11 to 17 to ensure the 
clarity of survey items, and we pre-tested the instrument with 26 parents from the national panel 
to ensure proper survey functionality. The full AVIP survey instrument is available online at 
www.unc.edu/~ntbrewer/hpv.htm. 
Predictor. The survey instructed parents to first “think about the pharmacy you would 
usually go to if you needed to get [child’s name] prescription medications,” and then asked 
parents to identify the pharmacy type. We combined chain pharmacy, a pharmacy in a grocery 
store, and a pharmacy in a big box store into the referent category (termed “chain pharmacies,” 
coded “0”), an independent pharmacy as a second category (coded “1”), and a pharmacy in a 
clinic or hospital as a third category (coded “2”). 
Mediators. The survey included items about parents’ service quality perceptions assessed 
in three factors adapted from work by Hedvall and Paltschick:82 professionalism, confidentiality, 
and milieu (five-point response scale ranging from “strongly disagree” [1] to “strongly agree” 
[5]; Appendix III). Three items represented the latent variable “professionalism”: the appraisal of 
the pharmacists keeping the customers’ best interests at heart, and performing their clinical 
duties promptly and accurately. Two items represented the latent variable “confidentiality”: the 
appraisal of the pharmacists creating an environment where customers feel that they are cared 
for, and enabling them to feel free to discuss problems and ask questions. Four items represented 
the latent variable “milieu”: the appraisal of physical premises of the pharmacy and appearance 
of the pharmacists. The survey also assessed parents’ feeling of overall satisfaction with health 
services at the pharmacy (seven-point response scale ranging from “completely dissatisfied” [1] 
to “completely satisfied” [7]). 
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Outcome. The outcome was willingness to get HPV vaccine from an immunizing 
pharmacist. Parents were first prompted with the statement “Imagine you and [child’s name] 
decided to get the HPV vaccine for [him/her]”. Parents were then asked “How willing would you 
be to have [child’s name] receive it from an immunizing pharmacist?” The four-point response 
scale ranged from “definitely not willing” to “definitely willing” (coded 1-4). 
Covariates. The survey company provided sociodemographic characteristics including 
parent sex, age, race and ethnicity, education, household income, urbancity (“non-metropolitan 
statistical area” or “metropolitan statistical area”), and U.S. region of residence. The survey 
included items from the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) that 
assessed parents’ HPV vaccine confidence.87 Two items assessed how many minutes it takes 
parents to get to the pharmacy and their child’s primary care provider.  One item assessed the 
parent’s familiarity with the pharmacists at the pharmacy they frequent (three-point response 
scale ranging from “not well at all” [1] to “very well” [3]). For demographic and health 
characteristics for the parent’s index child (reported by the parent), the survey assessed sex, age, 
race and ethnicity, HPV vaccinations status (“no doses,” “1+ doses,” or “series completion”), 
perceived health status (“poor health” [1] to “excellent health” [5]), and previous use of an 
alternative vaccination setting (defined as the index child having received a previous vaccination 
at a pharmacy, school, or health department). 
Statistical analyses 
One-way analysis of variance. First, we conducted one-way analysis of variance 
(ANOVA) to identify between group differences in mean scores on the three service quality 
appraisals, overall satisfaction, and willingness to get HPV vaccine from a pharmacist among the 
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pharmacy types parents typically use. We used Bonferroni multiple comparisons tests to evaluate 
the statistical significance between group scores. 
Confirmatory factor analysis. Second, we used confirmatory factor analysis (CFA) to 
evaluate the extent to which the nine service quality items loaded onto three, sufficiently distinct 
factors. Models considered to have excellent fit to the observed data on global fit indices had a 
root mean squared error approximation (RMSEA) of less than .05, and a Comparative Fit Index 
(CFI) and Tucker Lewis Index (TLI) of greater than .95.138 We also evaluated each model’s 
Schwarz’s Bayesian Information Criterion (BIC, Appendix IV). A difference of 10 or more in 
BICs between two competing models provides strong support for the model with the most 
negative BIC.139 We also looked at modification indices to evaluate if any indicators in the 
measurement model should be correlated based on sound theoretical justification.97 We used full 
information maximum likelihood estimation with robust standard errors, which uses Huber-
White sandwich estimators to account for possible non-normality in the distribution of the errors 
in the model.140 Finally, we evaluated internal consistency reliability of each factor using 
coefficient-ω (omega; Appendix III).102 The hypothesized three-factor model with an error 
correlation had superior fit compared to alternatives (RMSEA=.031, CLI=.99, TLI=.99, and 
BIC=-113; Appendix IV and Appendix V), and was used for the structural equation model 
(SEM). 
Structural equation modeling. Finally, we created a SEM to evaluate how the three 
service quality factors and overall satisfaction mediated the relationship between pharmacy type 
and parents’ willingness to get HPV vaccine for their children from pharmacists. We conducted 
our SEM analyses using full information maximum likelihood estimation using bootstrapped 
resampling procedures.140 We assessed the statistical significance of direct and indirect 
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(mediated) effects employing 5,000 random sample draws with replacement from the existing 
dataset to generate bias-corrected confidence intervals.141 Similar to the CFA, we examined 
model fit by evaluating its RMSEA, CFI, and TLI, and calculated BICs to compare our 
hypothesized model to alternative models (Appendix IV). Our results are based on the 
hypothesized model due to the presence of an association between one of the pharmacy type 
predictors and willingness outcome. 
Our initial SEM included the following covariates: parent’s sex, age, education, distance 
lived from pharmacy and child’s primary care provider, household income, urbanicity, U.S. 
region of residence, child’s sex, race and ethnicity, HPV vaccination status, and child’s 
perceived health status. We also adjusted for child’s age, child’s previous use of alternative 
settings for vaccinations, and parent’s HPV vaccine confidence based on findings from earlier, 
related studies.6,32,87,142,143 Our final SEM only included covariates that were associated with the 
willingness outcome (Table 6.3). All covariates were correlated with predictors and mediators to 
adjust for their effects. 
We used Stata 13.1 (College Station, TX) to run descriptive statistics and ANOVA. We 
used Mplus 7.4 (Los Angeles, CA) to run the CFA and SEM. All statistical tests were two-tailed 




Correlates of willingness to get HPV vaccine from immunizing pharmacists 
 Overall, 44% of parents were either probably or definitely willing to get HPV vaccine 
from a pharmacist (!=2.31, SD=.93). Parents’ average willingness varied by pharmacy type 
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(p=.046; Table 6.2); 45% of parents who went to chain pharmacies expressed willingness to get 
HPV vaccine from a pharmacist compared to 37% who went to independent pharmacies or 39% 
who went to pharmacies in clinics or hospitals. 
Pharmacy type. The hypothesized structural equation model fit the data well 
(RMSEA=.041; CFI=.97; TLI=.96; Figure 6.1). In analyses that controlled for covariates but not 
the mediators, parents who went to independent pharmacies reported lower willingness to get 
HPV vaccine (7=-.088; p=.001) compared to parents who went to chain pharmacies. After 
including the service quality latent variables and overall satisfaction measure as mediators in the 
SEM, the negative association between independent pharmacies and parents’ willingness to get 
HPV vaccine from pharmacists increased in magnitude (7=-.094; p=.001; Table 7.3 and Figure 
6.1). In contrast, there was no association between pharmacies located in a clinic or hospital 
(compared to chain pharmacies) and willingness to get HPV vaccine for analyses that controlled 
for only covariates and analyses that included mediators and covariates.  
 Covariates. Parents were more willing to get HPV vaccine from pharmacists if they had 
children previously vaccinated in alternative settings (7=.18; p<.001), if they knew their 
pharmacists moderately well (7=.11; p<.001) or very well (7=.07; p=.011), and had older 
children (7=.08; p=.002). Parents were less willing to get HPV vaccine from pharmacists if they 
had children identified as (7=-.05; p=.046), but were more willing if they had children 
categorized as Other (7=.08; p=.001). Willingness to get HPV vaccine remained lower for 
parents who identified their children as Black (7=-.05; p=.034) in analyses that only included 
parents of Black or White children (n=1,351). 
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Pharmacy type and service quality factors 
The three pharmacy types elicited different ratings of professionalism, confidentiality, 
and milieu (Table 6.2). Parents who went to independent pharmacies compared with parents who 
went to chain pharmacies gave higher appraisals of professionalism (4.24 versus 3.78; p<.001) 
and confidentiality (4.38 versus 3.98; p<.001). No difference was observed with regard to milieu. 
Parents who went to pharmacies located in clinics or hospitals compared with parents who went 
to independent pharmacies gave lower evaluations of professionalism (3.73; p<.001), 
confidentiality (3.95; p<.001), and milieu (3.79; p=.001). Parents gave higher ratings of milieu at 
chain pharmacies compared to pharmacies in clinics or hospitals (3.98 versus 3.79; p=.02), but 
ratings for professionalism and confidentiality did not differ. 
Mediation analyses 
Service quality to willingness to get HPV vaccine. Appraisals of professionalism (7=.22; 
p=.01) and milieu (7=.22; p=.02) were positively associated with overall satisfaction, while 
appraisal of confidentiality was not (7=.00; p=.97; Table 6.3). Overall satisfaction was positively 
associated with parents’ willingness to get HPV vaccine from pharmacists (7=.11; p<.001). 
Results from the mediation analyses (Table 6.4) show that the paths from professionalism 
(pathway product=.024, CI95%: .006-.054) and milieu (pathway product=.024, CI95%: .006-.051) 
were positive, statistically significant, and similar in magnitude. However, the path from 
confidentiality was not statistically significant. 
Pharmacy type to willingness to get HPV vaccine. Parents who went to independent 
pharmacies gave higher appraisals of professionalism (7=.17; p<.001), confidentiality (7=.14; 
p<.001), and milieu (7=.07; p=.03) compared to those who went to chain pharmacies. Parents 
who went to pharmacies located in clinics or hospitals gave lower appraisal of milieu (7=-.08; 
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p=.01) compared to those who went to chain pharmacies, but did not give different appraisals of 
professionalism (7=-.01; p=.63) or confidentiality (7=-.02; p=.60). In the mediation analyses for 
independent pharmacies compared to chain pharmacies, the sum of the mediating paths was 
statistically significant (pathway product=.006, CI95%: .002-.011). Among the individual paths 
between the independent pharmacy indicator and willingness outcome, only the mediating path 
including professionalism was statistically significant (pathway product=.004, CI95%: .001-.010). 
In the mediation analyses for pharmacies located in clinics or hospitals compared to chain 
pharmacies, the sum of all mediating paths, as well as the individual mediating paths including 
professionalism, confidentiality, and milieu were not statistically significant.  
 
DISCUSSION 
Marketing research has consistently shown service quality and satisfaction predict 
customer engagement in health care,144 banking,145 telecommunication,146 and tourism147 
industries. Similarly in our study, perceived service quality and overall satisfaction are predictors 
of parents’ willingness to get HPV vaccine for their children from pharmacists. Perceived service 
quality and satisfaction also varied by the type of pharmacy parents usually go to for their 
children’s prescription medications. This result supports the notion that customers’ perceived 
service quality is dependent on their interaction with service environments.77 
Inconsistent with our hypothesis 1, parents were less willing to get HPV vaccine from 
pharmacists if they usually went to independent pharmacies, and not different if parents usually 
went to pharmacies in clinics or hospitals compared to chain pharmacies. Parents’ willingness to 
get HPV vaccine was similar for those who usually went to independent pharmacies and 
pharmacies in clinics and hospitals, and both means were lower compared to parents who usually 
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went to chain pharmacies. The detection of an association in the SEM for the group of parents 
who used independent pharmacies but not one for the group who used pharmacies in clinics or 
hospitals may be due to insufficient statistical power. Independent pharmacies are likely to be 
less consistent in their appearances and types of non-dispensary services they provide for 
patients, which could lead parents to perceive them as less ideal for adolescent vaccinations as 
compared to chain pharmacies. Additionally, parents may be less willing to get their children 
HPV vaccine at pharmacies in clinics and hospitals by virtue of proximity to their children’s 
medical providers. 
Our second hypothesis was partially supported by the presence of a mediating effect of 
service quality factors and satisfaction between independent pharmacies to parents’ willingness 
to get HPV vaccine. Appraisals of service quality and feeling of satisfaction were high across 
pharmacy types, which may explain the small effect size seen through the mediated path. 
Consumer Reports also showed generally high appraisal of the different pharmacies they 
evaluated.137 Also of note,  Hedvall and Paltschik proposed that appraisals of professionalism 
and milieu are preconditions for service quality.82 Our findings corroborate their proposition as 
evidence of mediating paths from professionalism and milieu. In light of a negative association 
between willingness and independent pharmacies, service quality and satisfaction act as 
suppressors suggesting inconsistent mediation. As such, other important mediators may possibly 
help explain the negative relation between independent pharmacy type and parents’ willingness. 
For instance, the service quality factors and satisfaction item are global measures of an attitude 
and affect that do not take into account specific aspects that are important to vaccine delivery 
that parents consider when judging a location acceptable for adolescent vaccinations, such as 
perceptions of safety and privacy.5,6 In this study, our aim was to look at how a general attitude 
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towards a pharmacy type relates to parents engagement with a hypothetical service. Future 
studies that relate pharmacy service context with health service engagement, or look at 
implementation of quality improvement efforts in pharmacies, may benefit from survey 
instruments that include service quality and satisfaction items that are tailored to the specific 
service a consumer engages in, such as adolescent vaccination, at the point of service 
transaction.77 
Familiarity with pharmacists was also strongly associated with parents’ willingness, which 
may have been acting as a proxy for parents’ perceptions of trust with their pharmacists. Trust is 
a key predictor of medical service use and patient satisfaction.148 We found that the majority of 
our sample (61%) did not know their pharmacist at all. Lack of familiarity could be driven by 
pharmacists focused on administrative responsibilities and current business models that are 
dependent on reimbursement from dispensing services, rather than focused on cognitive services 
like medication therapy management and counseling.149 Pharmacies should find ways to promote 
patient-provider communication not only to make vaccinations more viable, but also to make 
pharmacies a more acceptable health care setting. Patient-pharmacist communication, in the form 
of patient education and counseling, is made all the more important in light of our finding that 
parents were more willing to get HPV vaccine from pharmacists as their confidence in HPV 
vaccination increased. 
This study has notable strengths, including a national sample of U.S. parents of adolescents 
and novel survey items examining various motivating factors that influence parents’ willingness 
to get HPV vaccine from pharmacists. The hypotheses were grounded in established theory on 
service quality, and provided a novel application of a marketing theory to the adolescent 
vaccination literature. The analytic approach of structural equation modeling allowed us to look 
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at complex mediation, model latent variables, and account for measurement error. Our study is 
limited by a cross-sectional study design that prevents us to establish temporal relationships 
among variables, thus limiting our inferences to associations. In addition, satisfaction and 
willingness can be conceptualized as multidimensional constructs, and the study would have 
benefited from multi-item measures. Parents also supplied their own responses to the survey, 
which can lead to response biases. Finally, our study was not designed to directly address 
perception differences of pharmacies or pharmacists due to racial and ethnic differences. The 
lower willingness in parents of Black compared to White children may be akin to other findings 
of medical mistrust with physicians,150 but a possible explanation for the association for “Other” 
race is ambiguous due to the necessity of combining racial categories to maintain statistical 
power. Future studies may be warranted to understand the modifying effects of race and ethnicity 
on perceptions of service quality and satisfaction in pharmacies. 
 
CONCLUSIONS 
With 77% of U.S. pharmacies providing vaccination servies,151 pharmacists can play a 
meaningful role in increasing HPV vaccine uptake. In our study, close to half of parents 
expressed willingness to get HPV vaccine from pharmacists, but their willingness varied by the 
type of pharmacy parents typical use. Service quality and satisfaction were key predictors of 
parents’ willingness, but notably so was parents’ familiarity with pharmacists. These correlates 
signal to the importance of looking to best practices in improving patient experiences at the 
pharmacies, particularly those that promote pharmacist-patient communication. 
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TABLE 6.1 SAMPLE DEMOGRAPHIC CHARACTERISTICS (N=1,504) 
	
 n or avg (%) or (SD) 
Parent Characteristics   
Sex   
Male 668 (44) 
Female 836 (56) 
Age (yrs) 43.9 (7.84) 
Race/Ethnicity   
Non-Hispanic White 1058 (70) 
Non-Hispanic Black 135 (9) 
Hispanic 212 (14) 
Other race/ethnicity 99 (7) 
Education   
High school degree or less 576 (38) 
Some college or more 928 (62) 
HPV vaccine confidence 3.65 (.77) 
Pharmacy type used for index child’s 
prescriptions   
Chain pharmacy 829 (55) 
Grocery store pharmacy 169 (11) 
Big box pharmacy 218 (15) 
Pharmacy in clinic or hospital 124 (8) 
Independent pharmacy 155 (10) 
Parent’s familiarity with pharmacist   
Not well at all 907 (61) 
Moderately well 479 (32) 
Very well 108 (7) 
   
Child Characteristics   
Sex   
Male 765 (51) 
Female 739 (49) 
Age (yrs) 14.0 (2.01) 
Race   
White 1175 (79) 
Black 160 (11) 
Other 153 (10) 
Ethnicity   
Non-Hispanic 1236 (83) 
Hispanic 258 (17) 
HPV vaccination status   
0 doses 808 (54) 
≥1 dose 458 (30) 
Series completion 237 (16) 
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Vaccinated in alternative settings   
No 994 (66) 
Yes 510 (34) 
   
Household Characteristics   
Household income   
Less than $35,000 329 (22) 
$35,000 - $74,999 470 (31) 
$75,000 or more 705 (47) 
Urbanicity   
Non-metropolitan statistical area 236 (16) 
Metropolitan statistical area 1268 (84) 
Region   
Northeast 261 (17) 
Midwest 393 (26) 
South 499 (33) 
West 351 (23) 





TABLE 6.2 PARENTS’ EVALUATIONS MEAN PROFESSIONALISM, CONFIDENTIALITY, MILIEU, OVERALL 
SATISFACTION, AND WILLINGNESS TO GET HPV VACCINE FROM PHARMACISTS BY PHARMACY TYPE 
	




n = 1216 
Independent 
pharmacy (SD) 
n = 155 
Pharmacy in 
clinic or hospital (SD) 
n = 124 
F p 
Professionalisma 3.78 (.88) 4.24 (.86) 3.73 (.86) 19.99 <.001 
Confidentialitya 3.98 (.85) 4.38 (.81) 3.95 (.89) 15.42 <.001 
Milieua 3.98 (.75) 4.14 (.82) 3.79 (.83) 7.11 <.001 
Overall satisfactionb 5.42 (1.51) 5.92 (1.45) 5.47 (1.56) 7.42 <.001 
Willingness to get HPV vaccinec 2.34 (.92) 2.18 (1.03) 2.19 (.96) 3.09 0.046 
Note. Total number of missing cases for each ANOVA were less than 1%.  
a Professionalism, confidentiality, and milieu were measured with five-point response scales (“strongly disagree” [1] to “strongly 
agree” [5]).  
b Overall satisfaction was measured with a seven-point response scale (“completely dissatisfied” [1] to “completely satisfied” [7]).  





TABLE 6.3 DIRECT EFFECTS OF PREDICTORS ON SERVICE QUALITY FACTORS, OVERALL SATISFACTION, 
AND WILLINGNESS TO GET HPV VACCINE FROM PHARMACISTS (N=1,504) 
	
Predictors Mediators Outcome 
  Professionalism Confidentiality Milieu Overall satisfaction Willingness 
Pharmacy type      
Chain pharmacy (ref) -  - - - - 




[.01, .12] - 
-.09** 
[-.15, -.04] 




[-.14, -.02] - 
-.04 
[-.09, .01] 
Service quality factorsa      
Professionalism -  - - .22* [.05, .40] - 
Confidentiality -  - - .00 [-.18, .16] - 
Milieu -  - - .22* [.05, .40] - 
Overall satisfaction -  - - - .11*** [.06, .16] 
Index child vaccinated in alternative settingsb      
No (ref) -  - - - - 
Yes -  - - - .18*** [.13, .23] 
Familiarity with pharmacistsb      
Not well at all (ref) -  - - - - 
Moderately well -  - - - .11*** [.06, .16] 
Very well -  - - - .07* [.02, .13] 
Index child's raceb      




Black -  - - - -.05* [-.09, -.001] 
Other -  - - - .08** [.03, .13] 
Index child's ageb  - - - .08** [.03, .12] 
HPV vaccine confidenceb -  - - - .17*** [.12, .23] 
Note. Estimate of coefficients (!) are standardized. 95% confidence intervals are bias corrected.  
*p <.05; **p<.01; ***p<.001.  
a Professionalism, confidentiality, and milieu were correlated with each other. 
b Model adjusted for statistically significant effects of covariates on willingness outcome variable. All covariates were correlated with 




TABLE 6.4 INDIRECT EFFECTS OF PHARMACY TYPE TO WILLINGNESS TO GET HPV VACCINE FROM 
PHARMACISTS 
Mediation paths " [CI95%] 
Professionalism via …   
Overall satisfaction à Willingness to get HPV vaccine from immunizing pharmacist .024* [.006, .054] 
Confidentiality via …    
Overall satisfaction à Willingness to get HPV vaccine from immunizing pharmacist .000 [-.021, .018] 
Milieu via …   
Overall satisfaction à Willingness to get HPV vaccine from immunizing pharmacist .024* [.006, .051] 
 
Independent pharmacy vs retail chain pharmacy via …  
 
Professionalism à Overall satisfaction à Willingness to get HPV vaccine from immunizing 
pharmacist  .004 [.001, .010] 
Confidentiality à Overall satisfaction à Willingness to get HPV vaccine from immunizing 
pharmacist  .000 [-.003, .003] 
Milieu à Overall satisfaction à Willingness to get HPV vaccine from immunizing pharmacist .002 [.000, .005] 
Sum of mediating effects .006* [.002, .011] 
Pharmacy in a clinic or hospital vs retail chain pharmacy via …   
Professionalism à Overall satisfaction à Willingness to get HPV vaccine from immunizing 
pharmacist .000 [-.002, .001] 
Confidentiality à Overall satisfaction à Willingness to get HPV vaccine from immunizing 
pharmacist  .000 [-.001, .001] 
Milieu à Overall satisfaction à Willingness to get HPV vaccine from immunizing pharmacist -.002 [-.005, .000] 
Sum of mediating effects -.002 [-.005, .000] 





FIGURE 6.1 STRUCTURAL EQUATION MODEL ASSESSING IMPACT OF PHARMACY TYPE ON WILLINGNESS TO 
GET HPV VACCINE FROM PHARMACIST 
	
 
Note. Numbers are standardized coefficients (!). Estimates of coefficients (!) in parentheses are the direct effects of pharmacy type 
on willingness to get HPV vaccine without controlling for mediators (only direct effect of independent pharmacy statistically 
significant). Goodness of fit tests: #$= 616; RMSEA = .041; CFI = .97; TLI = .96. Factor loadings, residuals, correlations between 
variables, and covariates were omitted to simplify presentation. Dashed lines represent statistically nonsignificant pathways. 
	
  92 
 
CHAPTER SEVEN. STUDY TWO: RELATIVE ADVANTAGES OF PHARMACIES 
AND DOCTORS’ OFFICES AS VACCINATION SETTINGS 
 
INTRODUCTION 
The President’s Cancer Panel and the National Vaccine Advisory Committee 
recommended expanding HPV vaccine provision in pharmacies to help improve access and 
opportunities for HPV vaccination,3,4 whose completion rates for U.S. adolescent boys (27%) 
and girls (37%) ages 13 to 15 remaining well below the Healthy People 2020 objective of 80% 
coverage for children these ages.134 Pharmacy-located vaccinations presents advantages for 
adolescents over vaccination in traditional medical settings given their convenient locations 
within communities,44,47,49 longer operating hours,44 and ability to administer vaccines with no 
appointment and short wait times.49 
Past studies5,6,58,60,108 have identified reasons why pharmacies may possibly be considered 
acceptable vaccination settings. However, no studies have directly evaluated how pharmacies 
compare to doctors’ offices based on important features of vaccine delivery. Within the context 
of Diffusion of Innovation (“DOI”) Theory, adolescent vaccination in pharmacies, particularly 
HPV vaccination, could be viewed as an innovation since adolescent vaccine delivery is a 
relatively new service provided by some pharmacies. Widespread adoption of an innovation like 
pharmacy-located adolescent vaccination depends on five traits: relative advantage, 
compatibility, complexity, trialability, and observability.109,110 Among these traits, relative 
advantage, “the degree to which an innovation is perceived as better than the idea it supersedes,” 
has been found to be the most important predictor for adoption.109 Vaccination in pharmacies and 
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doctors’ offices can be distinguished as having relative advantages based on important delivery 
features like safety and convenient hours. 
Parents who have reported positive attitudes about vaccinating their children in 
pharmacies or other alternative settings suggest that the main appeal of these settings is increased 
convenience or access to vaccination services.5,60 Based on these observations, we hypothesized 
that compared to doctors’ offices, parents believe pharmacies are superior vaccination settings 
when considering vaccine delivery features related to patient accessibility (hypothesis 1a). 
However, past research also showed parents and adolescents prefer going to traditional medical 
settings to get vaccines over alternative vaccination settings, including pharmacies,5,6,58,60,108 
expressing safety and privacy concerns.6,58 While parents’ positive attitudes for using alternative 
settings appear to be rooted in patient accessibility, parents’ preferences for vaccinating their 
children in traditional medical settings appear to be grounded in their expectations of what 
constitutes an acceptable clinical environment for vaccinations. Therefore, we also hypothesized 
that compared to doctor’s offices, parents believe pharmacies are inferior vaccination settings 
when considering vaccine delivery features related to the health care environment (hypothesis 
1b).  
Additionally, the saliency of the relative advantage of a vaccine delivery feature may also 
be important to consider when evaluating parents’ decision to get their children vaccinated from 
pharmacists. As such, we believe that parents who place the greatest importance on vaccine 
delivery features that relate to patient accessibility are more willing to get HPV vaccine from a 
pharmacist compared to parents who place the greatest importance on features that relate to the 
health care environment (hypothesis 2). We also believe, after controlling for the importance 
parents place on vaccine delivery features, parents who identify more relative advantages for 
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getting their children vaccinated at pharmacies have higher willingness to get their children HPV 
vaccine from a pharmacist (hypothesis 3). 
No previous studies have explicitly tested whether the perceived relative advantages of 
pharmacies, and the importance placed on these relative advantages, are associated with 
willingness to get HPV vaccine from pharmacists. For this study, we aimed to characterized how 
parents perceive relative advantages of vaccine delivery between pharmacies and doctors’ 
offices, and how these perceptions relate to parents’ willingness to get HPV vaccine for their 
children from pharmacists. 
METHODS 
Data source and procedures 
Study participants. The Adolescent Vaccinations in Pharmacies (AVIP) Study was an 
online, cross-sectional survey of U.S. parents of adolescents conducted from November 2014 to 
January 2015. Study participants were members of an existing, national panel of non-
institutionalized adults maintained by a survey company.83 The national panel was created 
through probability-based sampling of U.S. households using a combination of random-digit 
dialing and address-based sampling frames. Eligible respondents were parents of at least one 
child ages 11 to 17 who lived with them at least half of the time. Parents answered survey items 
about their children who they identified at the beginning of the survey.  
Analytic sample. The survey company randomly selected 2,845 parents from a panel 
comprised of members from all 50 states and the District of Columbia. Approximately 14% 
(n=391) of invited panelists were not eligible to complete the survey. Of the 2454 eligible 
parents, 1,518 completed some portion of the survey. After we excluded 14 panelists who did not 
complete at least two-thirds of the survey and four panelist who did not complete our study’s 
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variables of interest, our final analytic sample contained 1,500 parents whose sociodemographic 
characteristics are summarized in Table 7.1. The response rate was 61% (1,500/2,454) based on 
American Association for Public Research Response Rate Five.84,85 
Measures 
Survey item development. We developed survey items based on previous research with 
parents, adolescents, and health care providers,86-90 or adapted items from other sources.7,91,92 We 
cognitively tested the AVIP survey with a convenience sample of 18 parents of adolescents ages 
11 to 17 to ensure the clarity of survey items, and we pre-tested the survey with 26 parents from 
the national panel to ensure proper survey functionality. The full AVIP survey instrument is 
available online at www.unc.edu/~ntbrewer/hpv.htm.  
 Relative advantages of vaccine delivery by setting. The survey told parents to “imagine 
[child’s name] needed a vaccine such as tetanus booster, meningitis vaccine, or HPV vaccine. 
Also imagine these vaccines are available at pharmacies and doctors’ offices.” Then parents 
answered seven questions about whether a pharmacy or doctor’s office would be better at a 
particular vaccine delivery feature. Parents could respond by selecting “pharmacy”, “doctor’s 
office”, or “they’re the same”. The seven features were: 1) providing privacy during vaccination, 
2) being a safer place for vaccinations, 3) having more welcoming staff, 4) more likely to get 
vaccinated without an appointment, 5) taking less time for vaccinations, 6) more convenient 
hours for vaccinations, and 7) telling the cost of vaccines before delivery. Finally, parents were 
asked “which of these is most important when choosing between a pharmacy and a doctor’s 
office as a place to get [child’s name] vaccinated?” Parents responded by selecting the vaccine 
delivery feature they believed was most important.  
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The seven vaccine delivery features were conceptualized into two broad categories 
during analysis (Figure 7.1): “health care environment” and “perceived patient accessibility”. We 
coded the vaccine delivery feature items so that indicating a doctor’s office was better was “-1,” 
a pharmacy and doctor’s office were the same was “0,” and a pharmacy was better was “1.” We 
then summed the seven contrast-coded vaccine delivery feature items, and scaled it so that the 
relative advantage composite score ranged from “-1” to “1.” Therefore, parents who scored 
closer to -1 believed doctors’ offices had more relative advantages in adolescent vaccine 
delivery, while parents who scored closer to 1 believed pharmacies had more relative advantages 
in adolescent vaccine delivery. 
Outcome variable. The outcome of interest for this study is willingness to get HPV 
vaccine from an immunizing pharmacist. Parents were first prompted with the statement 
“Imagine you and [child’s name] decided to get the HPV vaccine for [him/her].” Parents were 
then asked “How willing would you be to have [child’s name] receive it from an immunizing 
pharmacist?” Parents indicate the extent of their willingness as “definitely not willing” [1] to 
“definitely willing” [4]. 
Sociodemographic characteristics. The survey company provided parent and household 
demographic characteristics including parent sex, age, race and ethnicity, education, household 
income, urbancity (“non-metropolitan statistical area” or “metropolitan statistical area”), and 
U.S. region of residence. The survey included five items about parents’ HPV vaccine confidence 
based on the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS).87 The survey 
also assessed what kind of pharmacy parents typically use for their child’s prescription 
medications (“chain pharmacy,” “independent pharmacy,” or “pharmacy in clinic or hospital”), 
and how many minutes it takes parents to get to that pharmacy. Additionally, the survey included 
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one item assessing parents’ familiarity with the pharmacists at the pharmacy they most frequent 
(“Not well at all” [1] to “Very Well” [3]). For demographic and health characteristics for the 
parent’s index child (reported by the parent), the survey assessed sex, age, race and ethnicity, 
HPV vaccinations status (“0 doses” or “≥1 dose”), and previous use of an alternative vaccination 
setting (defined as the child previously vaccinated at a pharmacy, school, or health department). 
Statistical analyses 
All analyses and missing data procedures were conducted in Stata 13.1. All statistical 
tests were two-tailed with critical !=.05. We used Huber-White sandwich estimators to account 
for possible non-normality in the distribution of the errors in the regression models,111 and report 
standardized "-coefficients for the multiple regression models. 
Analyses. First, we tested the equality of proportions to identify the different percentages 
of parents who believed a pharmacy or a doctor’s office was better at one of the seven vaccine 
delivery features, or if the two settings were the same (hypotheses 1a & 1b). Percentages of 
parents’ responses endorsing doctor’s office and pharmacy were different if they deviated from 
.5 (or 50%) based on the test statistic. Next, we evaluated how parents’ willingness to get HPV 
vaccine from pharmacists varied by the importance parents placed on the seven vaccine delivery 
features when deciding to get their children vaccinated at either a pharmacy or doctor’s office 
(hypothesis 2). We used a t-test to discern if mean willingness (outcome) differed between the 
two categories of vaccine delivery features (predictor: “health care environment” versus “patient 
accessibility”). We then conducted two analyses of variance (ANOVA) to ascertain if mean 
willingness to get HPV vaccine from pharmacists varied within each category’s vaccine delivery 
features.  
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For our third analysis, we evaluated how parents’ beliefs about the relative advantages of 
pharmacies and doctors’ offices in adolescent vaccine delivery were associated with willingness 
to get HPV vaccine from pharmacists (Hypothesis 3). We examined bivariate associations 
between parents’ willingness to get HPV vaccine with the relative advantage composite score 
and several other sociodemographic characteristics. All statistically significant correlates were 
combined in a multiple regression model. Lastly in an exploratory analysis, we evaluated how 
sociodemographic characteristics of parents and adolescents correlated with parents’ beliefs 
about the relative advantages of pharmacies and doctors’ offices in adolescent vaccine delivery 
using the composite variable we previously described (Appendix VI and Appendix VII). 
Similarly, we first examined bivariate associations and then combined all statistically significant 
correlates in a multiple regression model. 
Missing data procedure. Missing cases for each variable used for the analyses ranged 
from zero to two percent. We used multiple imputation by chained equations to estimate 
plausible values for missing data,152 and augmented regression procedures to avoid perfect 
prediction for incomplete categorical variables.153 A total of 20 imputed datasets were generated 
and merged. We compared regression coefficients using complete case analysis (n=1,404) with 
the imputed dataset (n=1,500) as a sensitivity analysis to check for biases. We found very little 
differences between the multiple regression models (Appendix VIII). As such, the regression 
results reported are from the imputed dataset. 
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RESULTS 
Parents’ evaluation of adolescent vaccine delivery features 
 The majority of parents believed doctors’ offices were better at adolescent vaccine 
delivery features related to the health care environment, while at the same time, believed 
pharmacies were better at adolescent vaccine delivery features related to patient accessibility 
(Table 7.2). Specifically, the majority of parents believed doctors’ offices were better at 
providing privacy during vaccination (77%), being a safer place for vaccination (70%), and 
having more welcoming staff (50%), while very few parents believed pharmacies were better at 
these features (providing privacy: 3%; safer place: 1%; more welcoming staff: 4%). All 
proportion tests showed significant differences between the proportion of parents who selected a 
doctor’s office and the proportion who selected a pharmacy on these three items (p < .001). 
By comparison, the majority of parents believed pharmacies were better for getting 
children vaccinated without an appointment (70%), having more convenient hours for 
vaccination (59%), taking less time for vaccination (50%), and telling the cost of vaccinations 
before administration (47%), while fewer parents believed doctors’ offices were better at these 
features (no appointment: 17%; more convenient hours 19%; taking less time: 30%; telling the 
vaccination cost: 18%). All proportion tests showed significant differences between the 
proportion of parents who selected a doctor’s office and the proportion who selected a pharmacy 
on these three items (p < .001). 
Willingness to get HPV vaccine by importance placed on vaccine delivery features 
 71% of parents identified vaccine delivery features related to the health care environment 
as being the most important consideration when choosing between a doctor’s office or pharmacy 
to get their child an adolescent vaccine (Table 7.2). The majority of parents (87%) indicated the 
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most important consideration was the safety of the setting, followed by privacy, getting 
vaccinations without an appointment, and convenient hours. Few parents (13%) said the most 
important considerations were taking less time to get their children vaccinated, explaining 
vaccination cost before administration, and having welcoming staff. 
44% of parents were either probably or definitely willing to get HPV vaccine from an 
immunizing pharmacist (#=2.31, SD=.93). Parents who placed the greatest importance on a 
vaccine delivery feature related to the health care environment had lower willingness to get HPV 
vaccine for their children from pharmacists (mean=2.14, SD=.89) compared to parents who 
placed the greatest importance on a vaccine delivery feature related to patient accessibility 
(mean=2.72, SD=.91; p<.001). No differences in willingness appeared among parents who 
selected vaccine delivery features within the health care environment category as their most 
important considerations (F=2.52; p=.08). Similarly, no differences in willingness appeared 
among parents who selected vaccine delivery features within the patient accessibility category as 
their most important considerations (F=.19; p=.90). 
Correlates of willingness to get HPV vaccine from pharmacists 
Willingness was higher among parents who believed there were more relative advantages 
in pharmacies ("=.29; p<.001; Table 7.3). Willingness was also higher among parents who were 
more familiar with their pharmacists ("=.13; p<.001), and had their children previously 
vaccinated in an alternative setting ("=.13; p<.001). Similarly, willingness was also higher 
parents who reported higher HPV vaccine confidence ("=.09; p<.001), had children who had at 
least one dose of HPV vaccine ("=.10; p<.001), and had children whose race was categorized as 
other or multiracial ("=.09; p<.001). Finally, willingness was lower among parents who usually 
went to independent pharmacies for their children’s prescription medications ("=-.06; p=.013). 
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DISCUSSION 
 To the best of our knowledge, this is the first study to directly compare parents’ beliefs 
about the vaccine delivery processes of pharmacies and doctors’ offices. Ultimately, the goal in 
making pharmacy-located adolescent vaccination more appealing to parents is to improve 
opportunities for adolescent vaccines, particularly HPV, and to create a perception of pharmacies 
as a setting that can be trusted in complementing adolescent vaccination efforts. This study 
applied DOI Theory to distinguish pharmacies from doctors’ offices on discrete vaccine delivery 
features. We found evidence that supported all our hypotheses, suggesting that framing the 
vaccine delivery process in pharmacies in terms of its relative advantages could be a fruitful way 
to increase parents’ interest in pharmacy vaccination services. 
Parents believed pharmacies excel at issues of patient accessibility in adolescent vaccine 
delivery, particularly at having more convenient hours and vaccinating without an appointment, 
consistent with Hypothesis 1a and 2. These findings track with parents’ sentiments about 
alternative vaccination settings, in general, convenience for vaccinations.5,60Additionally, parents 
endorsed these two features the most among those who considered patient accessibility the most 
important consideration for getting their children vaccines between a pharmacy and doctor’s 
office. Pharmacies that offer adolescent vaccination services should focus their advertisements 
on these two aspects of patient accessibility to make the services more appealing to parents. 
Our findings also showed that parents believed doctor’s offices were better at vaccine 
delivery when considering issues of the health care environment, consistent with Hypothesis 1b 
and 2. Pharmacies will need to improve perceptions of safety and privacy to increase their likely 
use as an adolescent vaccination setting, since parents selected them as the two most important 
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considerations for where to get their children vaccinated. Parents’ prioritization of safety and 
privacy expand upon the general safety and privacy concerns with alternative settings found in 
previous studies.6,58 We are unable to illuminate specific details of what parents believe 
constitutes a safe and private place for vaccinations, but possibly could include a clean space that 
is well equipped in case of adverse events, or one that accommodates anonymity during 
vaccination. Investigating these details is a potential avenue for future quality improvement 
research. Nevertheless, pharmacies that attend to desirable vaccine delivery attributes that are 
found in doctors’ offices may increase the its appeal as a vaccination setting, and improve 
parents’ overall image of pharmacies as a trusted place for broader health care needs. 
Care delivery indicators played the most important role in parents’ willingness to get 
HPV vaccine from pharmacist compared to HPV vaccine and sociodemographic indicators. 
Willingness was strongly associated with how doctors’ offices and pharmacies were perceived 
by their relative advantages in vaccine delivery, consistent with Hypothesis 3. This follows 
DOI,109 suggesting that pharmacies should stress the range of potential advantages parents 
currently perceive them to have over doctor’s offices to encourage more rapid adoption of 
pharmacy-located HPV vaccination. What was also striking was how willingness varied based 
on whether parents placed the greatest importance in vaccine delivery on the health care 
environment or patient accessibility. Together these two associations show that not only do 
parents need to perceive there are more relative advantages in pharmacy-located adolescent 
vaccinations over doctor’s offices, but parents may also be more prone to adopt pharmacy-
located adolescent vaccinations if the relative advantages (or enhancements) they see are relevant 
to their vaccine decision making. Similar to previous studies evaluating acceptability, 
convenience, and comfort with alternative vaccination settings,6,60,142 we found that parents’ 
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familiarity with pharmacists or having children who have been vaccinated in alternative settings 
had higher willingness to get their children HPV vaccine from pharmacists, implying that trust 
with vaccine providers and the setting itself are important factors for vaccine decision making. 
Furthermore, consumer data show that less than half of patients speak with pharmacists about 
their medications,137 making a case for pharmacists to improve their patient-provider 
communication as a means to increase parents’ trust in them as adolescent vaccinators. 
Our study had notable strengths, including a large national sample of parents and novel 
items comparing the vaccine delivery process between pharmacies and doctors’ offices informed 
by DOI Theory. This study was limited by the use of a cross-sectional design, which allowed us 
to infer associations of parents’ willingness to get HPV vaccine from pharmacists, but not the 
direction of these associations. Outcomes were self-reported, which can lead to response bias in 
certain survey questions such as their children’s vaccination history, or lead to an overestimation 
of willingness to get HPV vaccine from pharmacists. The interpretation of our findings is also 
limited by the lack of adolescent and health care provider perspective of the vaccine delivery 
process, which would have strengthened the relevance of our findings for improving pharmacy-
based vaccinations. While the study focused on several provider-level characteristics of vaccine 
delivery, other features of vaccine delivery maybe important to parents’ willingness to get HPV 
vaccine from pharmacists were not tested, such as potentially prohibitive out-of-pocket costs.34 
Finally, there may be other aspects of DOI Theory that are relevant to pharmacy-based 
adolescent vaccinations such as “observability”109 that we were unable to assess in our study. For 
example, some pharmacists who provide HPV vaccine have reported vaccinating all their 
eligible employees and own children as a means to publicize and normalize the service to 
clientele.154 
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CONCLUSION 
  Pharmacies present a promising complement to primary care clinics in adolescent HPV 
vaccination efforts due to their substantial reach within communities. An estimated 250 million 
visits are made to a pharmacy each week in the United States,135 and around 93% of people live 
within five miles of a pharmacy.38 In our study, we found that a large minority of parents would 
be willing to go to pharmacists for their children’s HPV vaccinations, demonstrating at the very 
least an openness to participating in these programs if they were made available. However, to 
achieve high adoption of pharmacy-based vaccinations, pharmacies must capitalize on their 
perceived advantages over doctors’ offices, such as vaccinating without appointments or having 
convenient operating hours, while also attending to vaccine delivery features parents believe to 
be superior at doctors’ offices such as safety and privacy during vaccination.
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TABLE 7.1 SAMPLE DEMOGRAPHIC CHARACTERISTICS (N=1,500) 
	
 n or mean (%) or (SD) 
Parent Characteristics   
Sex   
Male 665 (44) 
Female 835 (56) 
Age (mean years) 43.9 (7.84) 
Race/Ethnicity   
Non-Hispanic White 1,058 (70) 
Non-Hispanic Black 134 (9) 
Hispanic 212 (14) 
Other/multiracial 98 (7) 
Education   
High school degree or less 573 (38) 
Some college or more 927 (62) 
HPV vaccine confidence (mean score) 3.31 (.72) 
Pharmacy type used for child’s 
prescriptions   
Retail chain pharmacy 1,213 (81) 
Independent pharmacy 155 (10) 
Pharmacy in clinic or hospital 124 (8) 
Parent’s familiarity with pharmacist   
Not well at all 905 (61) 
Moderately well 478 (32) 
Very well 108 (7) 
   
Child Characteristics   
Sex   
Male 761 (51) 
Female 739 (49) 
Age (mean years) 14.0 (2.01) 
Race   
White 1,172 (79) 
Black 159 (11) 
Other 140 (10) 
Ethnicity   
Non-Hispanic 1,232 (83) 
Hispanic 258 (17) 
HPV vaccination status   
0 doses 805 (54) 
≥1 dose 694 (46) 
Child vaccinated in alternative settings   
No 991 (66) 





Household Characteristics   
Household income   
$0 - $35,000 328 (22) 
$35,000 - $74,999 468 (31) 
$75,000 or more 704 (47) 
Urbanicity   
Non-metropolitan statistical area 234 (16) 
Metropolitan statistical area 1,266 (84) 
Region   
Northeast 261 (17) 
Midwest 393 (26) 
South 496 (33) 
West 350 (23) 
Distanced lived from pharmacy used 
for child’s prescriptions (mean time in 
minutes) 
11.7 (11.7) 
Distanced lived from child’s doctor’s 
office (mean time in minutes) 17.7 (12.9) 




TABLE 7.2 WILLINGNESS TO GET HPV VACCINE FROM PHARMACISTS BY 
IMPORTANCE PLACED ON VACCINE DELIVERY FEATURES 
	
Vaccine delivery feature n Means (SD) 
Health care environmenta 1,050 2.14 (.89) 
Provide privacyb 146 1.99 (.83) 
Safe placeb 856 2.17 (.90) 
Welcoming staffb 48 2.10 (.81) 
Patient accessibilitya 424 2.72 (.91) 
No appointmentc 143 2.76 (.99) 
Convenient hoursc 136 2.69 (.90) 
Tells you vaccination costc 59 2.73 (.81) 
Takes less timec 86 2.69 (.88) 
 Note. Total sample is 1,474 parents. a t-test was statistically significant (p<.001); b One-way 
ANOVA was not statistically significant (p = .08); c One-way ANOVA was not statistically 
significant (p = .90)
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TABLE 7.3 CORRELATES OF WILLINGNESS TO GET HPV VACCINE FROM 
PHARMACISTS (N=1,500) 
	
 Bivariate " Multivariable " 
Care delivery indicators   
Relative advantage composite score .35*** .29*** 
Importance placed on vaccine delivery feature related to …   
Health care environment ref - 
Patient accessibility .28*** .20*** 
Parent’s familiarity with pharmacists .14*** .13*** 
Child vaccinated in alternative settings   
No ref - 
Yes .21*** .13*** 
Pharmacy type used for child’s prescriptions   
Retail chain pharmacy ref - 
Independent pharmacy -.05 -.06* 
Pharmacy in clinic or hospital -.05     .01 
HPV vaccine indicators   
Parent's HPV vaccine confidence .16*** .09*** 
Child's HPV vaccination status   
0 doses ref - 
≥1 dose .12*** .10*** 
Sociodemographic characteristics   
Parent's age  .06* .01 
Child's age  .09*** .04 
Child's race   
White ref - 
Black -.04 -.01 
Other/multiracial .09* .09*** 
Note. Table shows only associations significant in bivariate analyses except for pharmacy type. 
Variables that were not significant in bivariate analyses: Distance lived from pharmacy, distance 
lived from doctor’s office, primary health care decision maker, parent sex, Parent race/ethnicity, 
parent education, child sex, child’s ethnicity, household income, urbanicity, and region of 





FIGURE 7.1 PARENTS’ EVALUATION OF ADOLESCENT VACCINE DELIVERY FEATURES 
	
 

























CHAPTER EIGHT. STUDY THREE: IMPACT OF PHARMACISTS ON THE 




HPV vaccination surveillance studies have noted geographic variation in vaccine 
coverage. Several of these studies1,63,115,120,134 have shown variation in vaccine coverage across 
states and regions. Additionally, a growing body of state-specific studies62,116,119,155 have also 
identified substantial within-state variation in vaccine coverage. The geographic disparities in 
cancer incidence117,124 and mortality124 that potentially result from spatial patterns of HPV 
vaccination and screening suggest that spatial targeting of public health interventions may reduce 
geographic disparities. As an example, high cervical cancer burden in Appalachia is associated 
with low HPV vaccination coverage,125 a pattern that is repeated in analyses of state-level 
data.156 One way of understanding how these geographic disparities may arise is through 
understanding the distribution of health care workers available to a population as a way to 
measure health care access. 
The Behavioral Model of Health Care Utilization describes factors that enable health care 
utilization such as vaccination.122 Many of these enabling factors are at the individual level, such 
as higher income and having health insurance.122 Other enabling factors are at the community 
level, such as a neighborhood having more health care facilities and providers.122 Typically, in 
HPV vaccination research, most measures of health care examine access to and interactions with 
primary care providers such as pediatricians and family medicine physicians. This makes sense 
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as the vast majority of adolescent vaccinations are given in practices with these two specialties.33 
However, a 2010 study found a large portion of families with children have limited access to a 
primary care physician despite the substantial increase in physicians who see children in the 
United States.157 The potential maldistribution of primary care physicians taken together with 
evidence of lower health care use among adolescents30-32 may warrant additional modes of 
accessing care to improve vaccination coverage.  
Between 2014 and 2015, The President’s Cancer Panel and the National Vaccine 
Advisory Committee recommended expanding HPV vaccine provision in pharmacies to help 
improve access and opportunities for HPV vaccination.3,4 While community pharmacists 
typically do not provide adolescent vaccines, including HPV vaccine, they have a potentially 
meaningful role in expanding access in states that allow pharmacists to administer HPV vaccine 
to adolescents. This may be particularly germane in states like California and Texas where 
populations are dispersed across large geographic areas. The purpose of this study is to 
characterize the geographic distribution of primary care physicians who typically provide HPV 
vaccination in one state, Texas, and evaluate whether community pharmacists can improve 
access to HPV vaccination services in primary health care shortage areas.  
Some evidence suggests that people live closer to pharmacies than they do to their 
primary care providers. The National Association of Chain Drug Stores reported that 93% of 
U.S. residents live within five miles of a community pharmacy.38 The AVIP study showed that 
parents were closer to pharmacies where they usually go for their children’s prescriptions as 
compared to their children’s doctors’ offices (Table 5.1). The vast majority of pharmacies also 
have substantial retail operations which may allow them to be commercially successful in areas 
where primary care practices would struggle financially.  As such, we hypothesized that primary 
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care physicians are more spatially clustered than pharmacists (Hypothesis 1). Furthermore, if 
pharmacists are more dispersed geographically than primary care physicians, this dispersion may 
be especially important for high-need areas. That is, pharmacists may be able to increase access 
to vaccination services in areas with poor primary care provider coverage. As such, we also 
hypothesized that the number of areas with adequate health care provider coverage increases if 
pharmacists are included with primary care physicians as adolescent vaccine providers 
(Hypothesis 2). While other important health care professionals such as nurse practitioners and 
physician assistants also likely provide adolescent vaccines in Texas, we were unable to obtain 
sufficiently accurate practice address location or practice specialty information to include these 
providers in our study. Therefore, our study focuses on primary care physicians and community 
pharmacists who have the potential to provide HPV vaccine. 
 
METHODS 
Data sources and procedures 
 State selection. We focused our study on one state since pharmacy practice laws 
governing a pharmacist’s authority to vaccinate are state specific. We selected Texas based on 
inclusion and exclusion criteria we applied to the 48 contiguous states in the U.S., as well as the 
availability of necessary data to conduct our analyses. The two main inclusion criteria for states 
were 1) allowing pharmacists to vaccinate adolescents as young as 11 with HPV vaccine, and 2) 
having high participation rates among adolescents in the state immunization information system. 
Our exclusion criteria for state selection were 1) higher than national average HPV vaccination 
rates for boys and girls, and 2) small pharmacy work force. Based on these criteria, we selected 
Texas because it has a large population that is geographically dispersed, a large pharmacy work 
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force that could potentially provide HPV vaccine, and had high quality immunization data that 
could be used for future follow-up studies that relate neighborhood vaccination coverage with 
access to vaccine providers. 
Primary care physicians. Physician workforce data are publicly available from the Texas 
Medical Board (available at: http://store.tmb.state.tx.us/). Our dataset included physicians 
licensed by December 2016, and contained information about each physician’s sex, race and 
ethnicity, license status and registration dates, medical degree type, graduation year, primary and 
secondary specialties, practice type and setting, and full-time equivalent status. Four physicians 
(one pediatrician, one gynecologist, and two family medicine physicians) advised on the 
inclusion criteria used to identify primary care physicians from this dataset who are likely to 
provide adolescent vaccines. Inclusion criteria comprised of physicians who had an active 
practice license, a verifiable practice address in Texas that could be geocoded, and had a primary 
specialty in family medicine, general practice, obstetrics and gynecology, pediatrics, public 
health and preventive medicine, or urgent care medicine (Appendix IX). The final analytic 
sample had 12,307 primary care physicians. The majority of physicians were white (69%), non-
Hispanic (90%), held a doctor of medicine degree (88%), and practiced 40 or more hours per 
week (71%; Table 8.1). About half of the sample were male (51%), family medicine doctors 
(48%), and practiced in a partnership or group (47%). 
Community pharmacists. Pharmacist workforce data are publicly available from the 
Texas Board of Pharmacy (available at: http://www.pharmacy.texas.gov/dbsearch/tables.asp). 
Our dataset included pharmacists licensed by December 2016, and contained information about 
each pharmacist’s sex, race and ethnicity, license status and registration dates, pharmacy degree 
type, graduation year, and practice setting. Pharmacists were included in the analytic sample if 
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they had an active practice license, had a verifiable practice address in Texas that could be 
geocoded, and identified a community pharmacy as their employment type (Appendix IX).  The 
final analytic sample had 11,131 pharmacists. About half of pharmacists were male (47%), white 
(46%), and held a doctor of pharmacy degree (51%, Table 8.1). The majority of pharmacists 
practiced in a retail chain pharmacy (73%) 
Texas census tracts. We collected census tract geographic boundaries and demographic 
characteristics for Texas from the U.S. Census Bureau: 2016 TIGER/Line® shapefiles 
(census.gov/geo/maps-data/data/tiger-data.html). We used the 2010 Decennial Census for Texas 
population counts for each census tract. Texas has 5,254 census tracts with populations ranging 
from zero to 33,201 people (mean=4,786, SD=2,433). 
Geocoding procedures. First, we geocoded the physicians and pharmacists’ location as 
points using their given practice addresses. Next, in order to get counts of physicians and 
pharmacists at each geographic areal unit, the points representing the providers were joined to 
the shapefile containing the census tracts’ geographic boundaries and demographic 
characteristics. Only points that lay within the boundaries of each areal unit were counted as 
being contained within that unit. This process was conducted in ESRI ArcGIS 10.5 (Redlands, 
CA). 
Statistical analyses 
Spatial clustering of providers. First, we evaluated the extent of spatial clustering (spatial 
autocorrelation) of physicians and pharmacists in Texas with Moran’s I,129 using census tracts as 
the units of analysis. Moran’s I is a global test statistic that provides a summary over the entire 
study area of the level of spatial similarity observed among neighboring observations, 130 such as 
the number of physicians and pharmacists in census tracts. The formula for Moran’s I is: 
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Where n is the number of census tracts, yi and yj are the number of physicians or pharmacists in 
locations i and j, %&' is the neighbor spatial weight,	(,& − ,)(,' − ,)	is the covariance term, and 
(,& − ,)/(&)*  scales I to the overall variance in the dataset.  
We calculated spatial weights matrices using three different methods as a means to verify 
the robustness of our analysis. We used a contiguity neighbor method that used a first order 
queen criterion to identify adjacent observations to be included as “neighbors,” and use row 
standardization so that different census tracts are comparable to one another. We also 
recalculated the row standardized spatial weights matrix using inverse distance bands 
(thresholds), so the impact of providers in one census tract on another census tract decreased 
with distance. We used two approaches to calculate the inverse distance. The first inverse 
distance approach (designated “approach one”) set a threshold of 8,047 meters (5 miles) since 
93% of U.S. residents live within five miles of a pharmacy.38 If the distance from the centroid of 
one census tract to its nearest neighboring census tract was greater than 8,047 meters (e.g., a 
spatial outlier), we then specified a nearest neighbor parameter of at least one.158 The second 
inverse distance approach (designated “approach two”) allowed the spatial statistic software to 
maximize the inverse distance threshold so that all census tracts had at least one neighbor.158 We 
expected that as the method of creating the spatial weight matrix became more inclusive  for 
identifying neighbors (i.e., moving from continuity neighbors to inverse distance), the estimated 
value of Moran’s I would decrease. For the two inverse distance methods, we also calculated 
Moran’s I using both Euclidean and Manhattan distances, since Euclidean distances tend to 
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underestimate road distances and travel times, while Manhattan distances tend to overestimate 
both.159 
The interpretation of the Moran’s I test statistic is similar to the Pearson’s product-
moment correlation coefficient in that values range from -1 to 1. The null hypothesis is that the 
calculated value of Moran’s I is not different from the expected value (i.e., no spatial 
autocorrelation): 
0 ! = 	− 1$ − 1 
Where n is the number of census tracts. Values of I greater than the E(I) indicate positive 
autocorrelation (spatial clustering), while values of I less than the E(I) indicate negative 
autocorrelation (dispersion). To adjust for the tendencies of areas with larger populations to have 
more providers, we used rates of providers in each census tract for the Moran’s I statistical test 
by dividing the number of providers in each tract by the population in each census tract. Based 
on Hypothesis 1, we predicted that Moran’s I will be higher for the rate of physicians than the 
rate of pharmacists. Since Moran’s I is highly dependent on the unit of analysis, we conducted a 
sensitivity analysis by recalculating the test statistic at the county-level. We expected that 
Moran’s I would decrease as the units of analysis are aggregated. 
Provider rate change with pharmacist inclusion. Next, we descriptively analyzed how 
census tracts’ provider rates changed with the inclusion of pharmacists as a way to determine 
whether pharmacists can help improve access to HPV vaccination in areas with primary care 
health professional shortages. Primary care health professional shortage areas (HPSAs) are 
defined as having one or fewer full-time-equivalent primary care physician per 3,500 people 
living in a geographic area.160 Using the previously calculated physician and pharmacist rates, 
we standardized the rates per 3,500 people. We then added the two rates to get an overall 
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provider rate per 3,500 people. To address skewness, we winsorized (top coded) outlying 
provider rates to a value of 30 or more providers per 3,500 people (i.e., at or above 99th 
percentile). To evaluate if HPSAs moved to adequate provider coverage with the inclusion of 
pharmacists, we created two dichotomous variables. The first variable indicated whether a census 
tract had inadequate coverage (coded “0”) if the physician to population ratio was less than or 
equal to 1:3,500, or had adequate coverage (coded “1”) if the physician to population ratio was 
greater than 1:3,500. The second variable used the same coding scheme, but for physician and 
pharmacist to population ratio less than or equal to 1:3,500 (inadequate coverage coded “0”) or 
greater than 1:3,500 (adequate coverage coded “1”). We then examined the percentage of census 
tracts that shifted to adequate provider coverage when pharmacists were included in the provider 
rate.  
We performed several additional analyses. First, we conducted paired t-tests to compare 
the mean provider rates that only included physicians with rates that included both physicians 
and pharmacists. Second, we conducted sign tests to evaluate whether median provider rate 
increased when pharmacists were included along with physicians. Third, we stratified analyses 
by urban and rural census tracts using the 2010 Census classification, where tracts with a 
population greater than 2,500 were designated as urban areas (e.g., “urbanized areas” or “urban 
clusters”).161 We report provider rates at interquartile cutoffs to show how pharmacists change 
vaccine provider rates at the 25th, 50th, and 75th percentiles. Finally, we generated choropleth 
maps to visually depict where provider rates increased in Texas when pharmacists were included 
along with physicians in the rate calculations. 
The Moran’s I test statistic and choropleth map generation were conducted in ESRI 
ArcGIS 10.5. Data cleaning, manipulation, and statistical tests were conducted in Stata 13.1 
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(College Station, TX). All analyses used two-tailed statistical tests with a critical 2=.05. 
 
RESULTS 
Spatial clustering of providers 
In analyses at the census tract level, high physician rates tended to be located near other 
census tracts with high rates (i.e., spatial clustering). In analyses at the level of census tracts, 
physician rates exhibited spatial clustering in five of five analyses (median I=.04; Table 8.2). 
Spatial clustering was detectable using the contiguity neighbor method (I=.11, p<.001) and both 
inverse distance methods using Euclidian (approach one: I=.032, p<.001 approach two: I=.009, 
p<.001) and Manhattan distance calculations (approach one: I=.040, p<.001; approach two: 
I=.015, p<.001). However, pharmacist rates did not indicate any form of spatial dependence at 
the census tract level using any of the analytic approaches (median I=.00).  
In analyses at the county level, despite having positive Moran’s Is, physician rates did not 
show any spatial dependence using any of the analytic approaches (median I=.03). Pharmacist 
rates showed spatial clustering at the county level in two of five analyses (median I=.06). Spatial 
clustering was detectible using both inverse distance methods estimated by Manhattan distance 
calculations (Approach one: I=.095, p=.046; Approach two: I=.063, p=.033).   
Provider rate change with pharmacist inclusion 
 Adequate provider coverage with only primary care physicians was present in 33% of 
census tracts (1,720/5,254). When pharmacists were included, 55% of census tracts 
(2,867/5,254) had adequate provider coverage. Thus, among census tracts with inadequate 
provider coverage, 32% shifted to adequate coverage (1,147/3,534). A visualization of this shift 
appears in choropleth maps in Figure 8.1, where black (or grey) areas represent tracts with 
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adequate (or inadequate) provider coverage before and after including pharmacists. Among 
urban census tracts, 35% shifted towards adequate coverage with the inclusion of pharmacists 
(1,055/3013), while 18% of census tracts designated as rural shifted towards adequate coverage 
with the inclusion of pharmacists (92/521). 
 Mean provider rates increased when comparing physician-only rates with physician and 
pharmacist rates in both urban and rural census tracts (urban: t=-44.3, p<.001; rural: t=-11.8, 
p<.001; Table 8.3). The 25th percentile provider rates remained unchanged with the inclusion of 
pharmacists across the urban and rural stratifications. The median (50th percentile) rates 
increased from zero to 1.32 providers per 3,500 people (p<.001) with the inclusion of 
pharmacists, and the urban census tract rate increased from zero to 1.39 providers per 3,5000 
people (p<.001). However, the median rate among the rural tracts remained unchanged with the 
inclusion of pharmacists. Additionally, the 75th percentile provider rates all increased with the 
inclusion of pharmacists (Table 3). In urban areas, 2,413 census tracts had an increase in 
provider rate when pharmacists were included (n=4,508, p<.001), while in rural areas, 223 
census tracts had had an increase in provider rate when pharmacists were included (n=746; 
p<.001). A visualization of this rate change appears in choropleth maps in Figure 8.2, where 
darker blue areas represent areas with more providers per 3,500 people. 
 
DISCUSSION 
 The President’s Cancer Panel and the National Vaccine Advisory Committee prioritized 
the inclusion of community pharmacists as vaccinators to increase opportunities for HPV 
vaccination for adolescents.3,4 One way pharmacists may improve vaccination opportunities is by 
increasing geographic access to adolescent vaccination services. Our study findings suggest that 
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community pharmacists could improve health care provider coverage for vaccine delivery above 
and beyond what primary care physicians alone offer within communities. Pharmacists tended to 
be more geographically dispersed across census tracts than primary care physicians, and as a 
result were able to increase the availability of health care providers in areas with inadequate 
primary care provider coverage. However, we also recognize that travel impedance is not the 
only barrier to adolescent vaccination. If health care legislation extends pharmacists’ role to 
include adolescent vaccinations, pharmacists may have to address issues of in-network provider 
status by insurance companies to compensate pharmacists as vaccine providers,34,49 as well as 
allay any concerns medical organizations51-55 may have to the role pharmacists may play in 
furnishing adolescent vaccines. Pharmacies must also create a sustainable business case for 
providing adolescent vaccination services, and address vaccine delivery issues within their own 
practice settings to make them more appealing for parents and adolescents. To the best of our 
knowledge, our study is the first to directly compare the geographic distribution of primary care 
physicians with the distribution of community pharmacists, and it provides a preliminary step to 
further assess how pharmacists can alleviate geographic barriers to HPV vaccination. 
 Primary care physicians spatially clustered at the level of census tracts while pharmacists 
did not, providing support for Hypothesis 1. Economic processes may partially explain the 
different spatial patterns observed between the distribution of physicians and pharmacists. First, 
economies of scale, whereby the cost of rendering services reduces as the amount of services 
increases, may incentivize physicians to group together in larger practices, geographically 
clustering them. A recent study of primary care found that larger practices had smaller ratio of 
non-physician staff (including administrative staff, RNs, and PAs) per physician, likely because 
physicians can share this resource.162 Second, as primary care remuneration structures shift from 
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fee-for-service to value-based, primary care practices may be compelled to be more integrative 
with other providers in order to address health care needs of patient, and meet quality metrics set 
forth for compensation.163 Third, physicians have stronger network ties to other physicians who 
share similar patient panel characteristics.164,165 Since medical practices tend to provide a limited 
number of services by virtue of practice specialization (i.e., practices may tend not to overlap in 
scope), it would be reasonable to believe that they would gain financially by being able to refer 
patients to each other as a way to increase their patient caseload to achieve economies of scale. 
As such, physicians who create formal referral networks are likely to be geographically close to 
each other.164 
Compared to physicians in our study, the relative geographic dispersion of pharmacists may 
be primarily facilitated by economies of scope, whereby the cost of rendering services at 
pharmacies decreases with an increase in the diversity of services provided.166 Pharmacies are 
typically attached to retail outlets like grocery and department stores, achieving profitability by 
selling variety of products and services. This retail emphasis in turn could incentivize pharmacy 
businesses, and thus the location of pharmacists who practice there, to be geographically 
dispersed to avoid competition with each other, and located closer to where consumers work and 
live for easier access. Additionally, the diversification of products and services provided at a 
pharmacy business, particularly in retail chain operations, can allow them to remain fiscally 
solvent despite potential losses that can occur due to poor reimbursement from insurance 
providers for pharmacy services. While both economies of scale and scope provide compelling 
hypotheses for how spatial patterns arise for these two health care provider types, there is a real 
paucity of research that provide an empirical basis for these assertions, particularly for the 
pharmacy workforce. Additionally, economies of scale and scope are two processes that are not 
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mutually exclusive, and both physician and pharmacy practices may pursue both methods to 
achieve economic efficiency. 
Pharmacists were also able to improve health care provider coverage, consistent with 
Hypothesis 2. While both urban and rural areas appeared to have an increase in provider 
coverage as pharmacists were included, this effect was more pronounced in urban areas, where 
nearly twice as many urban census tracts moved to adequate provider coverage compared to rural 
census tracts. Additionally, based on interquartile cutoffs, we saw larger increases in provider 
rates in both urban and rural areas that already had some physicians. One reason for these 
patterns of increased provider adequacy in certain census tracts is the consequence of an 
ecological Matthew effect, where areas that already have economic advantage (e.g., at least some 
amount of access to primary care providers) will continue to accumulate other resources at a 
faster rate (e.g., the availability of pharmacists in those area), widening disparities with 
disadvantaged areas that do not exhibit the same growth.167 A previous study conducted by 
Rosenthal and colleagues found that residents in metropolitan areas in 23 states were more likely 
to have geographic access to physicians compared to residents in rural areas using three different 
measures of access: physician-to-population ratios, distance traveled, and caseload per 
physician.168 This preferential location of physicians in more urban areas may also be true for 
pharmacists. Pharmacists, like physicians, may tend to provide care in areas with larger 
population growth and community wealth.168 However, as urban markets become saturated, the 
retail model that increasingly drives pharmacy businesses may encourage them to spill over to 
markets with lower demands such as rural areas, called the “sand pile” hypothesis,168 as 
Rosenthal and colleagues found when modeling geographic access to physician over time. Future 
studies evaluating the migration of pharmacists across geographic boundaries may improve our 
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understanding of economic motivators for pharmacist practice location decisions and services 
they provide. This in turn, could help policy makers develop incentives for pharmacists to 
provide certain medical services in disadvantaged areas to alleviate geographic disparities in 
health care access. Additionally, since pharmacists tend to improve coverage where there are 
already some primary care physicians, identifying other public health strategies may be required 
to insure access to vaccination services in areas that do not have any health care providers.  
The method of analyzing spatial dependence is fundamentally important for the interpretation 
of our findings. We calculated Moran’s I using three different methods for generating spatial 
weights. Our findings were robust to the different methods employed, but as expected, we 
observed that spatial dependence decreased as we used increasingly more inclusive methods for 
identifying neighbors to generate the spatial weight matrices. Since we are primarily interested in 
how hypothetical HPV vaccination access would change if community pharmacists started 
providing the vaccine along with primary care physicians, we would want to select a method for 
identifying spatial neighbors that could rationally approximate likely geographic access of these 
providers. As a result, the contiguity neighbor method using a first order queen approach is likely 
too restrictive in identifying neighbors, since people living in urban areas can easily cross several 
census tracts to access a health care provide who administers HPV vaccine. Conversely, an 
inverse distance the sets a distance threshold too large (84 km or 52 mi as in approach two in 
Table 2) will be too inclusive in identifying neighbors, as people living in urban areas are likely 
not traveling great distances to access vaccination services. Therefore, our inverse distance 
approach, where we set the distance threshold to five miles and applies a nearest neighbor 




The unit of analysis (census tracts vs counties) substantially affected our findings, as shown 
by our sensitivity analysis. Analyses for counties showed no spatial dependence for either 
physician or pharmacist rates using Euclidean distance calculations, but spatial dependence for 
pharmacist rates using Manhattan distance calculations. However, as noted earlier in our 
methods, Manhattan distance calculations tends to overestimate drive distance and time, and 
could exaggerate distance traveled between counties. Euclidean distances may be more 
appropriate for county level analyses based on a visualization of Texas highways and roads 
across county lines (www.texas-map.org/road-map.htm). County level analysis of provider rates, 
and potentially vaccination rates, may be reasonable in rural areas where census tracts may 
approximate the sizes of counties, and rural residents are likely willing to travel longer distances 
for health care services.169 Our findings could suggest that while pharmacists may be somewhat 
spatially clustered in rural areas, the lack of spatial clustering of primary care physicians may be 
an indicator that physicians are better positioned to provide adolescent vaccination services in 
rural areas. However, using counties as units of analysis may not be appropriate in urban areas, 
where residents are far less likely to travel long distances to access care, and health care barriers 
move from being one of travel impedance (e.g., distance and time) to one more dependent on 
socioeconomic factors like income and insurance status.168,169 Therefore, when assessing health 
care service availability and accessibility, using smaller units of analysis facilitates the 
granularity that may be needed to evaluate different issues of health care access faced in rural 
and urban areas. Based on our findings from this sensitivity analysis, the challenges faced in 
rural areas in accessing HPV vaccination may not be adequately addressed by the availability of 
community pharmacists, as mentioned earlier, and thus, other public health strategies may be 
necessary to improve access to vaccination services in those areas. 
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 Strengths of our study include use of a comprehensive and accurate list of primary care 
physicians and community pharmacists from the Texas Medical Board and Board of Pharmacy. 
We also used geospatial analysis to understand the patterns of these two provider types, a novel 
method in evaluating health care work force that takes into account the spatial dependence of our 
observations. Additionally, we used census tracts as units of analysis to evaluate provider 
location and rates, which are both geographically and economically meaningful units as opposed 
to zip code tabulation areas, which are not rational geographic markers and can lead to 
representational error in spatial analyses.133 Notwithstanding, our study findings should be 
interpreted in light of several limitations. Our study assumed that all included primary care 
physicians and community pharmacists either provide, or have the potential to provide HPV 
vaccine, while in reality many of these providers may not be providing this vaccination service. 
Additionally, we were unable to model the geographic distribution of nurse practitioners and 
physician assistants who also play an significant role in adolescent vaccinations. As such, the 
true effect that pharmacists have in improving the adequacy of provider coverage may be smaller 
areas of our study. Finally, while we adjusted the number of providers in each census tract by 
population as a method of measuring adequate provider coverage, several other ways exist for 
measuring potential and realized access to providers by using distance lived to providers, public 
transit access, caseload per provider, and other sociodemographic indicators (e.g., cultural, 
language, or financial) that do not derive health care access barriers to distance alone. Examining 





 Community pharmacists could help to meaningfully improve the adequacy of health care 
providers who can administer HPV vaccination due to their substantial reach and availability in 
communities.34,49 Our study was descriptive in nature, and future workforce studies should 
account for individual and community factors that may be associated with provider locations. 
Additionally, future studies that correlate provider workforce availability with vaccination 
coverage can help elucidate how geographic patterns in HPV vaccination may occur, and also 
help identify areas for targeted public health interventions to address vaccination disparities. This 
may further the policy case to include pharmacists as adolescent vaccine providers, especially if 
future studies find evidence that pharmacists are well positioned to furnish care for medically 
underserved or vulnerable populations. 
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TABLE 8.1 TEXAS PRIMARY CARE PHYSICIAN (N=12,307) AND COMMUNITY 
PHARMACIST (N=11,131) CHARACTERISTICS 
	
 n or avg (% or SD) 
Physician characteristics   
Sex   
Male 6,219 (51) 
Female 6,085 (49) 
Race   
White 8,471 (69) 
Asian or Pacific Islander 2,092 (17) 
Black 905 (7) 
Other 839 (7) 
Ethnicity   
Non-Hispanic 11,067 (90) 
Hispanic 1,240 (10) 
Degree   
Doctor of medicine 10,829 (88) 
Doctor of osteopathic medicine 1,478 (12) 
Specialty   
Family medicine 5,906 (48) 
Pediatrics 3,574 (29) 
Obstetrics & gynecology 2,348 (19) 
General practice 373 (3) 
Urgent care medicine 80 (<1) 
Public health & preventive medicine 26 (<1) 
Average years since graduation 23 (22) 
Practice setting   
Partnership & group 5,781 (47) 
Solo 2,787 (23) 
Direct medical care 1,605 (13) 
Hospital 1,426 (12) 
Medical school 541 (4) 
Military 95 (<1) 
Health management organization 51 (<1) 
Public health service 21 (<1) 
Practice hours per week   
40 hours or more 8,782 (71) 
20-39 hours 2,866 (23) 
11-19 hours 338 (3) 
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1-10 hours 271 (2) 
Not applicable 50 (<1) 
   
Pharmacist characteristics   
Sex   
Male 5,213 (47) 
Female 5,899 (53) 
Race & ethnicity   
White 5,078 (46) 
Asian or Pacific Islander 2,505 (22) 
Black 1,900 (17) 
Hispanic 1,205 (11) 
Other 228 (2) 
Not specified 215 (2) 
Degree   
Doctor of pharmacy 5,575 (51) 
Bachelor of science 5,460 (49) 
Average years since graduation 20 (14) 
Practice setting   
Retail chain pharmacy 8,100 (73) 
Independently owned pharmacy 2,820 (25) 
Government facility pharmacy 211 (2) 
Note. Frequencies for specific characteristics may not total 12,307 physicians or 11,131 




TABLE 8.2 GLOBAL TEST OF SPATIAL AUTOCORRELATION OF PHYSICIAN AND PHARMACIST RATES: 
MORAN'S I 
	
 Physicians Pharmacists 
 Euclidean Manhattan Euclidean Manhattan 
 Moran’s I p Moran’s I p Moran’s I p Moran’s I p 
Census tract         
Contiguity neighborsa .11 <.001 - - -.0005 .50 - - 
Inverse-distance (approach one)b .032 <.001 .040 <.001 -.0002 .91 -.0002 .17 
Inverse-distance (approach two)c .009 <.001 .015 <.001 -.0004 .13 -.0004 .10 
County         
Contiguity neighborsa .045 .19 - - .044 .20 - - 
Inverse-distance (approach one)b .034 .34 .036 .42 .050 .17 .095 .046 
Inverse-distance (approach two)c .016 .52 .023 .40 .057 .05 .063 .033 
Note. The expected value of Moran’s I for 5,254 census tracts is -.00019. The expected value of Moran’s I for 254 counties is -.0039. 
aNeighbors were assigned using first-order queen method. Contiguity neighbor method does not depend on Euclidean and Manhattan 
distance calculations. 
bDistance bands set to 8,047 meters for census tracts and 73,468 meters for counties. A minimum of one identified neighbor was 
specified in cases where the distance measured from the centroid of a census tract (or county) to nearest neighboring census tract (or 
county) was >8,047 meters for census tracts and >73,468 meters for counties. 
cDistance bands was optimized to 84.25 km (Euclidean; census tract), 97.60 km (Euclidean, counties) and 118.69 km (Manhattan; 




TABLE 8.3 VACCINE PROVIDERS PER CENSUS TRACT (RATER PER 3,500 
PEOPLE) 
	
  Provider rate at each percentile 
 Mean (SD)a 25th percentile 50th percentile 75th percentile 
Physicians     
Overall 1.73 (4.19) 0 0 1.59 
Urban 1.64 (3.83) 0 0 1.56 
Rural 2.31 (5.89) 0 0 1.72 
Physicians & pharmacists     
Overall 3.38 (6.13) 0 1.32 4.08 
Urban 3.23 (5.41) 0 1.39 4.05 
Rural 4.38 (9.33) 0 0 4.36 
Note. Based on analyses of data for 5,254 census tracts (4,508 urban and 746 rural). Census 
tracts are designated urban areas if they have at least 2,500 people based on the 2010 Census 
Urban and Rural Classifications.  

















CHAPTER NINE. DISCUSSION 
 
OVERVIEW 
The structure in which the United States provides health care is changing. Addressing 
current and future population health needs is predicated on the ability to rapidly train (or even 
retrain) and deploy health professionals that can easily work within practice models that are 
patient-centered. With that in mind, delivery of some health care services must expand beyond 
traditional medical settings into new delivery channels,170 with the objectives of providing 
patients quality health care with greater access, more convenience, and lower costs. This is 
particularly true for low-cost services like vaccination that can be realistically provided outside 
of doctors’ offices with comparable quality of care. As a case study of this concept, my 
dissertation examined pharmacists’ preparedness to address poor HPV vaccination rates in U.S. 
adolescents. 
The President’s Cancer Panel and National Vaccine Advisory Committee included 
pharmacists as potential vaccine providers within their strategic frameworks to improve HPV 
vaccination rates for U.S. adolescents.3,4 Since 1994, pharmacists have played an increasingly 
large role in immunizations that protect the public against infectious disease.35 Pharmacists are 
established immunizers for adult,43 and have tremendous potential reach within communities; 
consumers make an estimated 250 million visits to pharmacies each week,135 and about 93% of 
U.S. residents live within five miles of a community pharmacy.38 Pharmacies also have longer 
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operating hours and are easier to access within communities compared to traditional medical 
settings when considering vaccination services.44,46-48 A recent systematic review and meta-
analysis of 36 studies found that pharmacists were able to increase vaccination coverage when 
they were involved in the immunization process compared to vaccination efforts conducted by 
traditional medical settings that did not include pharmacists.171 As such, this dissertation aimed 
to understand the intrapersonal, provider, and structural factors related to pharmacies as 
vaccination settings that might motivate parents to obtain pharmacist-provided HPV vaccinations 
for their children.  
 
SUMMARY OF FINDINGS 
To address my first specific aim, I examined the relationship between the type of 
pharmacy parents use and their willingness to have pharmacists administer HPV vaccine to their 
children. Parents who typically used independent pharmacies had a lower willingness to get their 
children vaccinated from pharmacists compared with parents who typically used retail chain 
pharmacies. Additionally, parents’ perceived service quality at the pharmacy and their feelings of 
overall satisfaction with services at the pharmacy mediated this relationship; higher perceptions 
of service quality were associated with a higher feeling of satisfaction, which in turn was 
associated with a higher vaccination willingness. While only a third of parents knew their 
pharmacists, parents’ who were familiar with their pharmacists were more willing to have 
pharmacists administer HPV vaccine to their children. This measure may have been a proxy for 
parents’ perceptions of trust or safety with their pharmacists. 
To address my second specific aim, I evaluated how parents perceived relative 
advantages of vaccine delivery in pharmacies compared to doctors’ offices, and how perceived 
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relative advantages of vaccine delivery are associated with parents’ willingness to get their 
children HPV vaccine from pharmacists. Parents believed pharmacies excelled in adolescent 
vaccine delivery when considering issues of patient accessibility, such as taking less time and 
convenient vaccination hours. Parents also believed doctors’ offices were superior in adolescent 
vaccine delivery when considering issues of the health care environment, such as safety and 
privacy. Parents who perceived more relative advantages in vaccine delivery in pharmacies were 
more willing to get HPV vaccine from pharmacists. Additionally, parents who placed the 
greatest importance on vaccine delivery features related to patient accessibility were more 
willing to get HPV vaccine from pharmacists compared to parents who placed the greatest 
importance on features related to the health care environment. 
Finally, to address my third specific aim, I evaluated whether pharmacists could improve 
access to HPV vaccination services in areas that may be considered primary health care shortage 
areas. In geospatial analysis of Texas, the rate of primary care physicians spatially clustered 
while the rate of community pharmacists did not at the census tract level. In my analysis of 
provider rate changes with pharmacist inclusion, pharmacists were able to improve health care 
provider coverage across census tracts. Of note, while both urban and rural areas appeared to 
have an increase in provider coverage as pharmacists were included along with primary care 
physicians, this effect was more pronounced in urban areas, where nearly twice as many urban 
census tracts moved to adequate provider coverage compared to rural census tracts. 
 
PUBLIC HEALTH IMPLICATIONS  
The dissertation findings contribute to HPV vaccination research in two important ways. 
First, findings related to my first two specific aims establish an empirical basis for improving the 
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quality of pharmacy practice as it relates to adolescent vaccinations. These studies help deepen 
our knowledge for factors that may influence parents to use pharmacy-based adolescent 
vaccination programs for their children. For specific aim one, I found that a parents’ willingness 
to get their children HPV vaccine from pharmacists varied by the type of pharmacy they 
typically go to for their children’s medications. Pharmacies that wish to engage established and 
new patients to participate in new adolescent vaccination services can potentially do so by 
improving the perceptions of service quality at the point of care. Additionally, for specific aim 
two, I found that while parents believed pharmacies were superior to doctors’ offices when it 
came to improving patient accessibility for adolescent vaccine delivery, parents also placed 
greater importance on delivery features that related to safety and privacy, two areas where 
parents believed doctor’s offices were superior to pharmacies. As such, pharmacies must 
improve their image as a health care setting in order for them to be viewed as a more acceptable 
place for adolescent preventive care. 
The second way my dissertation contributes to HPV vaccination research is by providing 
a starting point to investigate how pharmacists can improve opportunities for HPV vaccination 
by addressing potential geographic disparities that exist in primary care. Parents and their 
children who face greater barriers to accessing a primary care provider may benefit from 
additional points of cares within their communities that make it convenient for them to access 
preventive services. In specific aim three, I found that pharmacists were able to improve provider 
rates in areas where there was a potentially inadequate number of primary care providers. This in 
turn serves communities’ health needs by allowing families the option to get their adolescent 
children vaccinated in settings that are potentially more convenient than primary care clinics. 
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Including pharmacists as adolescent vaccine providers also makes better use of an existing health 
workforce with experience as immunizers. 
 
FUTURE RESEARCH 
Future studies should attempt to measure parents’ actual use of adolescent vaccination 
services for their children at pharmacies rather than behavioral willingness or intention to 
vaccinate. I used behavioral willingness (parents’ willingness to get their children HPV vaccine 
from pharmacists) as the primary outcome in studies related to my first two research aims 
primarily because so few parents have ever engaged in pharmacy-located (or pharmacist-
administered) vaccinations for their adolescent children. Unlike behavioral intention, behavioral 
willingness requires little precontemplation of the behavior or its consequences,172-174 and is 
conducive to measure likely behavior in hypothetical situations. As such, measuring willingness 
was reasonable as the vast majority of my study subjects had never engaged in pharmacist-
administered vaccinations, nor had they likely thought to have their children vaccinated by 
pharmacists. Behavioral willingness is highly correlated with behavioral intention,172,173 and both 
constructs are validated proximal antecedents for a wide variety of behaviors.175-178 While it is 
true that behavioral intentions overestimate actual behavior,175,179 and likely so does behavioral 
willingness, the correlated of willingness and behavior may be similar. Future studies should 
focus on evaluating parents and adolescents’ realized use of vaccination services, and the 
motivating factors that lead to their use, to guide quality improvement efforts in pharmacy-
located vaccinations.  
Another future direction for pharmacy-located HPV vaccination research is to evaluate 
how the pharmacy workforce can address vaccination disparities within communities. My third 
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study was limited by only looking at how provider rates changed when community pharmacists 
were included. However, the study does provide a compelling justification to further assess if the 
addition of community pharmacists can actually increase uptake of vaccines in adolescents. To 
the best of my knowledge, few studies have looked at the geographic distribution of pharmacists, 
or relate how the distribution of the pharmacy workforce can address particular health care needs 
like poor vaccination rates. 180-183 As shown in study three, analyses using global information 
systems can explicitly and accurately model workforce distributions, and could be a fruitful way 
of developing spatial econometric models that relate sociodemographic characteristics with the 
availability and accessibility of health care workforce like pharmacists, as well as health 
outcomes like vaccination rates. This in turn, can help public health practitioners develop and 




APPENDIX I. HEDVALL & PALTSCHIK’S DEFINITIONS OF THE 10 SERVICE QUALITY COMPONENTS AND 
THEIR CORRESPONDING DIMENSIONS 
	
Service quality constructs Definitions Dimensions 
Credibility Trustworthiness and honesty of the pharmacist. It involves having the customer's 
best interest at heart Commitment 
Reliability Dispensing the medicine accurately, correctly priced and in the time promised to 
the customer 
Security The freedom from risk or doubt that confidential information about the customer's 




Making the effort to understand his/her needs, finding out his/her specific 
requirements and giving individual attention. 
 
Accessibility 
Approachability and ease of contact. Ideally, the pharmacy is easy to reach, the 
opening hours are convenient, the products well displayed, the items in the self-
service sector easy to find and the pharmacy is easily contactable by phone. Milieu 
Tangibles 
physical attributes of the pharmacy, such as the size of the premises, equipment 
furnishings and whether there is a comfortable place to wait while prescriptions are 
being made up. 
Communication 
The customer is informed about prescription and non-prescription medicines, other 
products, dosages, side-effects, contraindications, questions concerning health and 
related matters, prices of services and products in a language the consumers 
understand. Such information is given orally and/or in writing. 
Professionalism 
Competence The pharmacist's possession of the skills and knowledge necessary to perform his 
or her duties in the pharmacy. 
Courtesy Politeness, respect, consideration and friendliness 
Responsiveness The willingness and readiness to perform the service required by the customer. It 
also includes having an available stock of all the medicines required. 





APPENDIX II. AIM ONE AND TWO MEASURES 
	
Aim 1 variables 
Variable type Construct Item Response scale 
Predictor Pharmacy type Think about the pharmacy you would usually go 
to if you needed to get [CHILD’S NAME] 
prescription medications. 
 
This pharmacy is …  
1 = A chain pharmacy (like CVS 
or Walgreens) 
2 = A pharmacy in a grocery store 
(like Kroger or Safeway) 
3 = A pharmacy in a big box store 
(like Target or Walmart) 
4 = A pharmacy in a clinic or 
hospital where [CHILD’S 
NAME] receives medical care 
5 = An independent pharmacy 
 
 Prompt The next questions are about the pharmacists 
and the pharmacy where you would usually get 
[CHILD’S NAME] prescription medications. 
 
Say how much you agree or disagree with the 
next statements. 
 
Mediator 1 (v1) Professionalism When I have problems, the pharmacist is 
sympathetic and reassuring. 
1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 
5 = Strongly agree 
 
Mediator 1 (v2) Professionalism 
 
 
The pharmacist responds to my requests 
promptly. 
1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 





Mediator 1 (v3) Professionalism The pharmacist gives me personal attention. 1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 
5 = Strongly agree 
 
Mediator 2 (v4) Confidentiality I can trust the pharmacist. 1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 
5 = Strongly agree 
 
Mediator 2 (v5) Confidentiality I feel safe in my interactions with the pharmacist.  1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 
5 = Strongly agree 
 
Mediator 3 (v6) Milieu The pharmacist is well dressed and appear neat. 1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 
5 = Strongly agree 
Mediator 3 (v7) Milieu This pharmacy has operating hours convenient to 
me. 
1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 
5 = Strongly agree 
Mediator 3 (v8) Milieu This pharmacy is visually appealing. 1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 




Mediator 3 (v9) Milieu 
 
This pharmacy’s appearance is what I would 
expect from a place that provides quality health 
care. 
1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 
5 = Strongly agree 
 
Mediator 4 Satisfaction Overall, how satisfied are you with the health 
services you have received at the pharmacy where 
you usually get [CHILD’S NAME] prescription 
medications? 
1 = Completely dissatisfied  
2 = Mostly dissatisfied  
3 = Somewhat dissatisfied  
4 = Neither satisfied or 
dissatisfied  
5 = Somewhat satisfied  
6 = Mostly satisfied  
7 = Completely satisfied  
 
Aim 2 variables 
Variable type Construct Item Response scale 
  Imagine [CHILD’S NAME] needed a vaccine 
such as tetanus booster, meningitis vaccine, or 
HPV vaccine. Also imagine these vaccines are 
available at pharmacies and doctor’s offices.  
 
Would a pharmacy or a doctor’s office … 
 




3=They’re the same 
 




3=They’re the same 
Predictor (IV3) No appointment … Be more likely to vaccinate [CHILD’S 
NAME] without an appointment? 
1=Pharmacy 
2=Doctor’s office 




Predictor (IV4) Convenient 
hours 




3=They’re the same 
 
Predictor (IV5) Know cost … Be more likely to tell you the cost of the 
vaccine before giving it to [CHILD’S NAME]?  
1=Pharmacy 
2=Doctor’s office 
3=They’re the same 
 
Predictor (IV6) Privacy … Be more likely to provide privacy while 
[CHILD’S NAME] is vaccinated? 
1=Pharmacy 
2=Doctor’s office 
3=They’re the same 
 
Predictor (IV7) Welcoming … Be more likely to have staff who are 
welcoming?   
1=Pharmacy 
2=Doctor’s office 
3=They’re the same 
 
Predictor (IV8) Importance Which of these is most important when choosing 
between a pharmacy and a doctor’s office as a 
place to get [CHILD’S NAME] vaccinated? 
 
 
1 = Be a safe place to get 
vaccinated 
2= Take less time to get 
vaccinated 
3 = Not require an appointment 
4 = Have more convenient hours 
of operation 
5 = Tell you the cost of the 
vaccine before giving it 
6 = Provide privacy while getting 
vaccinated 









Aim 1 and 2 outcome variable 





Imagine you and [CHILD’S NAME] decided to 
get the HPV vaccine for [HIM/HER]. 
How willing would you be to have [CHILD’S 
NAME] receive it from an immunizing 
pharmacist? 
 
1 = Definitely not willing 
2 = Probably not willing 
3 = Probably willing 
4 = Definitely willing 
Aim 1 and 2 covariates 





Say how much you agree or disagree with the 
next statements. 
 
Vaccines are necessary to protect the health of 
children [CHILD’S NAME]’s age. 
1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 






Vaccines do a good job in preventing the diseases 
they are intended to prevent. 
1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 






Vaccines are safe. 1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 






If I do not vaccinate [CHILD’S NAME], 
[HE/SHE] may get a disease such as meningitis 
and cause other teenagers or adults also to get the 
disease.  
 
1 = Strongly disagree 
2 = Somewhat disagree 
3 = Neither disagree or agree 
4 = Somewhat agree 









I feel that the tetanus booster for [CHILD’S 
NAME] is … 
1 = Not important 
2 = Slightly important 
3 = Moderately important 
4 = Very important 







I feel that the meningitis vaccine for [CHILD’S 
NAME] is … 
1 = Not important 
2 = Slightly important 
3 = Moderately important 
4 = Very important 







I feel that the HPV vaccine for [CHILD’S 
NAME] is … 
1 = Not important 
2 = Slightly important 
3 = Moderately important 
4 = Very important 





Many children get vaccines at places other than 
their doctor’s office. 
 
Has [CHILD’S NAME] ever received a vaccine 
at a … (Check all that apply.) 
1 = Pharmacy 
2 = School 
3 = Health department 






Which vaccines has [CHILD’S NAME] received 
at a pharmacy? (Check all that apply.) 
 
1 = Tetanus booster 
2 = Meningitis vaccine 
3 = HPV vaccine 
4 = Flu vaccine 
5 = Another vaccine 
Possible covariate 
(CV17) 
Ethnicity Is [CHILD’S NAME] Hispanic or 
[ETHNICITY]? 
[IF A32 = 1 “MALE”, THEN “ETHNICITY” = 
“Latino”] 
[IF A32 = 2 “FEMALE”, THEN “ETHNICITY” 
= “Latina”] 
0 = No 










Race What is [CHILD’S NAME]’s race or ethnicity? 
(Check all that apply.) 
1 = White 
2 = Black or African American 
3 = Asian 
4 = Native Hawaiian or Pacific 
Islander 
5 = American Indian or Alaska 
Native 







In general, would you say [CHILD’S NAME]’s 
health is: 
 
1 = Excellent 
2 = Very good 
3 = Good 
4 = Fair 






In your household, who is the main person who 
makes decisions about [CHILD’S NAME]’s 
health care? 
1 = You 
2 = Your spouse or partner 
3 = [CHILD’S NAME] 







APPENDIX III.  LATENT AND OBSERVED VARIABLES USED IN THE MEASUREMENT AND STRUCTURAL 
MODELS 
	
Measures Indicator wording Factor loading 
Latent variables   
Professionalism I1: When I have problems, the pharmacist is sympathetic and reassuring. .86 
Coefficient-ω = .88 I2: The pharmacist responds to my requests promptly.  .89 
 I3: The pharmacist gives me personal attention.  .85 
Confidentiality I4: I can trust the pharmacist.  .93 
 Coefficient-ω = .82 I5: I feel safe in my interactions with the pharmacist.  .95 
Milieu I6: The pharmacist is well dressed and appear neat.  .78 
 Coefficient-ω = .75 I7: This pharmacy has operating hours convenient to me.  .75 
 I8: This pharmacy is visually appealing.a  .81 
 I9: This pharmacy’s appearance is what I would expect from a place that 
provides quality health care.a  .82 
HPV vaccine confidence The HPV vaccine might cause lasting health problems. .74 
Coefficient-ω = .70 The HPV vaccine is being pushed to make money for drug companies. .87 
 I don’t have enough information about the HPV vaccine to decide whether to 
give it to [CHILD’S NAME]. .44 
 The HPV vaccine is effective in preventing cervical cancer. .41 
 It would be hard to find a provider or clinic where I can afford HPV vaccine 
for [CHILD’S NAME]. .27 
Observed variables   
Pharmacy typeb Think about the pharmacy you would usually go to if you needed to get 
[CHILD’S NAME] prescription medications. This pharmacy is …  
— A chain pharmacy (like CVS or Walgreens) , A pharmacy in a grocery store 
(like Kroger or Safeway), A pharmacy in a big box store (like Target or 
Walmart), A pharmacy in a clinic or hospital where [CHILD’S NAME] 






Overall satisfaction Overall, how satisfied are you with the health services you have received at the 
pharmacy where you usually get [CHILD’S NAME] prescription medications? 
—Completely dissatisfied, Mostly dissatisfied, Somewhat dissatisfied, Neither 
satisfied or dissatisfied, Somewhat satisfied, Mostly satisfied, Completely 
satisfied 
N/A 
Willingness to get HPV 
vaccine from a pharmacist 
Imagine you and [CHILD’S NAME] decided to get the HPV vaccine for 
[HIM/HER]. How willing would you be to have [CHILD’S NAME] receive it 
from an immunizing pharmacist? 
 — Definitely not willing, Probably not willing, Probably willing, Definitely 
willing 
N/A 
Index child's age How old is [CHILD’S NAME]?  
— 11 years old, 12 years old, 13 years old, 14 years old, 15 years old, 16 years 
old, 17 years old 
N/A 
Index child's race/ethnicityc What is [CHILD’S NAME]’s race or ethnicity?  
— White, Black or African American, Asian, Native Hawaiian or Pacific 
Islander, American Indian or Alaska Native, Other, please specify: [open 
ended] 
N/A 
Index child vaccinated in an 
alternative settingd 
Many children get vaccines at places other than their doctor’s office. Has 
[CHILD’S NAME] ever received a vaccine at a …  




How well do you know the pharmacists who work at this pharmacy?  
— Not well at all, Moderately well, Very well N/A 
Note. Loading factors are standardized. N/A = Not applicable. Response scales are 1-5, Strongly disagree to strongly agree unless 
otherwise noted in the table. 
a Indicators’ errors were correlated. 
b Pharmacy type variable in SEM was categorized to 0 = Retail chain pharmacy (chain pharmacy, grocery store pharmacy, big box 
pharmacy), 1 = Pharmacy in a clinic or hospital, 2 = Independent pharmacy. 
c Child’s race/ethnicity indicator in SEM was categorized to 0 = White, 1= Black or African American, 2 = Other. 





APPENDIX IV. GLOBAL FIT MEASURES FOR MEASUREMENT MODELS AND STRUCTURAL EQUATION 
MODELS 
	
 !" p df RMSEA CFI TLI BIC* 
Measurement modela        
Single-factor model 567 <.001 27 .115 .90 .87 369 
Three-factor model 99 <.001 24 .046 .99 .98 -76 
Three-factor model with correlated errors 55 <.001 23 .031 .99 .99 -113 
Structural Equation Modelb        
Hypothesized model 616 <.001 175 .041 .968 .955 -664 
Complete mediation 631 <.001 177 .041 .968 .955 -664 
Direct effects only 594 <.001 170 .041 .970 .957 -650 
Note. a!" reported for measurement models are scaled for maximum likelihood robust (MLR) estimations.  





APPENDIX V. MEASUREMENT MODEL OF PERCEIVED SERVICE QUALITY AT A PHARMACY 
	
 




APPENDIX VI. STUDY TWO EXPLORATORY ANALYSIS 
 
RESULTS 
The mean relative advantage composite score was -.06 (SD=.44). 42% of parents 
believed there were more relative advantages in vaccine delivery in pharmacies compared to 
doctors’ offices (composite score > 0). Parents who believed there were more relative advantages 
in pharmacies placed the greatest importance on vaccine delivery features related to patient 
accessibility (!=.20; p<.001). Parents who also believed there were more relative advantages in 
pharmacies had their children previously vaccinated in an alternative setting (!=.10; p<.001), 
reported higher HPV vaccine confidence (!=.08; p=.003), and had household incomes of 
$35,000 to $74,999 (!=.09; p=.01) or $75,000 or more (!=.09; p=.026). Parents who believed 
there were more relative advantages in doctors’ offices lived farther away from the pharmacy 
they use for their children’s prescription medications (!=-.08; p=.001), usually go to pharmacies 
in clinics or hospitals for their children’s prescription medications (!=-.15; p<.001), had children 
who had at least one dose of HPV vaccine (!=-.10; p<.001), and identified as either non-
Hispanic Black (!=-.12; p<.001) or Hispanic (!=-.14; p<.001).  
 
DISCUSSION 
We found parents’ importance placed on patient accessibility to be positively related to 
parents’ beliefs about the relative advantages between pharmacies and doctors’ offices, again 
suggesting that beliefs about relative advantages between pharmacies and doctor’s offices, and 
the saliency of these relative advantages to parents’ vaccine decision making should be jointly 
considered when evaluating vaccine quality improvement efforts in pharmacies. Our analysis 
also revealed a negative association between distanced lived to the pharmacy and relative 
advantage beliefs, which implies that living farther away from the pharmacy would make it less 
accessible or convenient to use for vaccination, the attributes that pharmacies excel at over 
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doctors’ offices. It also makes sense that parents who typically use pharmacies in clinics or 
hospitals would believe there were more relative advantages at doctors’ offices considering both 
settings are located near each other. Interestingly, parents who identified as non-Hispanic Black 
or Hispanic saw more relative advantages in doctors’ offices compared to parents who identified 
as White. These racial and ethnic differences may be similarly related to documented medical 
mistrust with physicians,150 although our study was not designed to address this issue with 
perceptions about pharmacies or pharmacists, directly. Future studies that characterize the 
beliefs, attitudes, and adolescent vaccination behaviors in pharmacies among racial and ethnic 
minorities could help identify ways pharmacies can provide more culturally appropriate care.  
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APPENDIX VII. CORRELATES OF RELATIVE ADVANTAGES IN VACCINE 
DELIVERY 
	
 Bivariate	! Multivariable	! 
Care delivery indicators   
Importance placed on vaccine delivery feature related to …   
Health care environment ref - 
Patient accessibility .28*** .20*** 
Child vaccinated in alternative settings   
No ref - 
Yes .10*** .10*** 
Distanced lived from pharmacy used for child’s 
prescriptions -.13*** -.08** 
Pharmacy type used for child’s prescriptions   
Retail chain pharmacy ref - 
Independent pharmacy -.04  -.05 
Pharmacy in clinic or hospital -.17*** -.15*** 
HPV vaccine indicators   
Parent's HPV vaccine confidence .07*  .08* 
HPV vaccination status   
0 doses ref - 
≥1 dose -.10*** -.10*** 
Sociodemographic characteristics   
Parent sex   
Male ref - 
Female -.07* -.04 
Parent age .08* .03 
Parent education   
High school degree or less ref - 
Some college or more .11*** .04 
Parent race & ethnicity   
Non-Hispanic white ref - 
Non-Hispanic black -.15*** -.12*** 
Non-Hispanic other/multiracial  -.05 -.03 
Hispanic -.17*** -.14*** 
Household income   
Less than $35,000 ref - 
$35,000 - $74,999 .13*** .09* 
$75,000 or more .21*** .09* 
Note. Table shows only associations significant in bivariate analyses. Variables not significant in 
bivariate analyses: Familiarity with pharmacists, distance lived from doctor’s office, Primary 
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health care decision maker, child sex, child age, child race/ethnicity, urbanicity, region of 
residence.	!-coefficients are standardized regression coefficients. * p<.05; ***p<.001
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APPENDIX VIII. COMPLETE CASE VERSUS IMPUTED DATASET ANALYSIS: 





multivariable analysis ! 
(n = 1,404) 
Multiple imputation 
multivariable analysis ! 
(n = 1,500) 
Care delivery indicators   
Relative advantage composite 
score .29*** .29*** 
Importance placed on vaccine 
delivery feature related to …   
Health care environment ref ref 
Patient accessibility .21*** .20*** 
Parent’s familiarity with 
pharmacist .12*** .13*** 
Child vaccinated in alternative 
settings   
No ref ref 
Yes .13*** .13*** 
Pharmacy type used for child’s 
prescriptions   
Retail chain pharmacy ref ref 
Independent pharmacy -.05 -.06* 
Pharmacy in clinic or hospital .02     .01 
HPV vaccine indicators   
Parent's HPV vaccine confidence .10*** .09*** 
Child's HPV vaccination status   
0 doses ref ref 
≥1 dose .09*** .10*** 
Sociodemographic characteristics   
Parent's age  .01 .01 
Child's age  .04 .04 
Child's race   
White Ref ref 
Black -.02 -.01 
Other .09*** .09*** 
Note. !-coefficients are standardized regression coefficients. 
* p<.05; ***p<.001 
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APPENDIX IX. FLOW DIAGRAM OF INCLUSION CRITERIA 
	
Total physicians in Texas dataset as of Dec. 2016
n =  128,407
Keep if living in Texas with verifiable practice address
n =  75,978
Keep those:
§ With an active medical practice licenses 
§ Provide charity care
n =  60,732
Keep those who:
§ Provide direct patient care
§ Are involved in medical teaching
§ Are completing residency or fellowship
n =  58,963
Keep those who practice in:
§ Partnership & group
§ Solo
§ Direct medical care
§ Military
§ Health management organization
§ Public health service
n =  55,337
Keep those whose primary specialties are:
§ Family medicine
§ General practice
§ Obstetrics & gynecology
§ Pediatrics
§ Public health & preventive medicine
§ Urgent care medicine
n =  15,046





§ Obstetrics & gynecology
§ Pediatrics
§ Public health &  preventive medicine
§ Sports medicine
§ Urgent care medicine
§ Unspecified/do not have one
n =  12,307
Primary care physician Community pharmacist
Total pharmacists in Texas dataset as of Dec. 2016 
n =  45,454
Keep if living in Texas with verifiable practice address 
n =  18,976
Keep those with active pharmacy practice licenses 
n =  18,835
Keep those who practice in:
§ Retail chain pharmacies
§ Independent pharmacies
§ Government facility pharmacies
n =  11,131
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